A Oneindia Venture

Directors Report of Albert David Ltd.

Mar 31, 2025

Your Directors are pleased to present the 86th Annual Report of the Company and the audited Financial Statements for the financial year ended 31st March, 2025. The PDF version of the Report is also available on the Company''s website at www.albertdavidindia.com/annualreport.php.

SUMMARY OF FINANCIALS OF THE COMPANY:

('' in Lakhs)

Particulars

FY 2024-25

FY 2023-24

Revenue from operations

34,576.79

36,246.17

Other Income

2,958.08

5,755.21

Total income

37,534.87

42,001.38

Earnings before Interest, Depreciation, Tax & Amortization

3,260.70

10,443.15

Finance Costs

41.04

32.12

Gross Profit (EBDTA)

3,219.66

10,411.03

Depreciation and Amortization

696.89

682.52

Profit before Tax (PBT)

2,522.77

9,728.53

Tax expense

802.69

2,186.52

Profit for the year (PAT)

1720.08

7,542.01

Other Comprehensive Income

(113.50)

112.45

Total Comprehensive Income for the year

1606.58

7,654.46

Retained Earnings - Opening Balance

23,876.85

16,552.87

Profit for the year

1720.08

7,542.01

Dividend paid on Equity Shares during the year

(656.32)

(513.64)

Realised Gain on sale of Equity Instrument transferred to Retained Earnings (Net of taxes)

50.22

259.45

Remeasurement of defined benefit obligation transferred to Retained Earnings (Net of taxes)

(81.52)

36.16

Total Retained Earnings

24,909.31

23,876.85

The Company has prepared the Financial Statements in accordance with the Companies (Indian Accounting Standards) Rules, 2015 prescribed under Section 133 of the Companies Act, 2013 (the "Act").

PERFORMANCE DURING THE YEAR & STATE OF THE COMPANY''S AFFAIRS:

We registered annual Revenue from Operations of ''345.77 Crores in FY 2025 compared to '' 362.46 Crores in FY 2024. Profit Before Tax for FY 2025 stood at '' 25.23 Crore compared to 97.29 Crores from FY 2024. In FY 2025, ADL invested in strengthening the field force of the company for future growth. The investment made in manpower and other marketing related expenses will bear fruit in future. We are confident that the company will grow from strength to strength in the days to come, ensuring that we continue to remain a highly profitable, compliant and socially responsible company.

Some of the highlights of the operations for the year are:

• Revenue from operations for the year was ''345.77 Crores in FY 2025 compared to '' 362.46 Crores in FY 2024.

• Profit Before Tax for FY 2025 stood at '' 25.23 Crores compared to '' 97.29 Crores from FY 2024

• Tax Provision for the current year amounted to '' 802.69 Lakhs for FY 2025 as against a tax provision of '' 2,186.52 Lakhs for FY 2024.

• Profit after Tax (PAT) stood '' 1720.08 lakhs for FY 2025 as against a PAT of '' 7,542.01 Lakhs for FY 2024.

• Earnings Per Equity Share of par value of '' 10/- each works out to ''30.14/- for FY 2025 as against ''132.15/- for FY 2024.

Your Directors are also striving to achieve further growth in sales and better financial performance in the forthcoming years.

DIVIDEND:

Your Directors are pleased to recommend a dividend of '' 5.00 per equity share of '' 10/- each, i.e. 50% for the FY ended March 31, 2025, subject to approval of members at the 86th Annual General Meeting. The Dividend, if approved by the members at the ensuing Annual General Meeting, will be paid to all those equity shareholders of the Company whose names appear in the Register of Members and/or Register of Beneficial Owners as on the record date and will result into a cash outflow of ''285.36 Lakhs.

RESERVES:

During the year under review, no amount was transferred to any of the reserves by the Company.

MATERIAL CHANGES AFFECTING THE COMPANY:

There have been no material changes and commitments in the business operations of the Company affecting the financial position, which has occurred between the end of the financial year of the Company to which the financial statements relate and the date of this report.

DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS:

> The Company has a system of Internal Audit to take care of the Internal Control systems, effectiveness of its functioning and the workflow of the organization in terms of the approved policies of the Company. Every quarter, the Internal Auditors present their Internal Audit Report along with management''s comments and action taken reports thereon before the Audit Committee of the Company;

> Your Board has adopted various policies, related to Related Party Transactions, Whistle Blower Mechanism and other procedures for ensuring the orderly and efficient conduct of business. The Company''s system of Internal Control has been designed to provide a reasonable assurance with regard to the maintenance of proper accounting controls, monitoring of operations, safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records and timely preparation of reliable financial information.

> The Company has ERP suite for a reliable, high-end, comprehensive, disciplined and integrated business solution.

> The Company is complying with all the applicable Indian Accounting Standards (Ind AS).The accounting records are maintained in accordance with generally accepted accounting principles in India. This ensures that the financial statements reflect the true and fair financial position of the Company.

DEPOSITS:

During the year under review, your Company has neither accepted/renewed any deposits nor has any outstanding Deposits in terms of Section 73 - 76 of the Companies Act, 2013 read with Companies (Acceptance of Deposits) Rules, 2014.

AUDITORS & THEIR REPORTS:

STATUTORY AUDITORS:

M/s. L. B. Jha & Co., Chartered Accountants (ICAI Firm Registration No. 301088E), Kolkata, were appointed as the Statutory Auditor of the Company at the 83rd Annual General Meeting held on August 9, 2022 to hold office from the conclusion of the said meeting till the conclusion of the 88th Annual General Meeting to be held in the year 2027.

They have confirmed that they are not disqualified from continuing as Statutory Auditors of the Company. The Report given by the Statutory Auditors on the Company''s financial statements is enclosed with this Report.

The Statutory Auditors had not reported any fraud under Section 143(12) of the Companies Act, 2013, therefore no detail in the said regard is required to be disclosed under Section 134(3)(ca) of the Companies Act, 2013.

The Notes on financial statements referred to in the Auditors'' Report are self-explanatory and does not call for any further comment. The Auditors'' Report does not contain any qualification, reservation, adverse remark or disclaimer.

SECRETARIAL AUDITOR:

Pursuant to the provisions of Section 204 & 134(3) of the Companies Act, 2013 read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 framed thereunder, the Board had appointed M/s. Vinod Kothari & Co., Practicing Company Secretaries (FRN: P1996WB042300), Kolkata, to undertake Secretarial Audit of the Company for the financial year ended March 31, 2025 and their Report in the prescribed Form MR - 3 is attached as "Annexure - 1" to this Report. The Secretarial Audit Report for F.Y 2024-25 does not contain any qualification, reservation or adverse remark except "there has been some gaps in filing of forms with ROC and the company is in the process of filing the same". Your company will regularize such gaps. The Company is in compliance with the Secretarial Standards, specified by the Institute of Company Secretaries of India.

Further, Pursuant to the provisions of Section 204 & 134(3) of the Companies Act, 2013 read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 framed thereunder, the Board had appointed M/s. MKB & Associates, Company Secretaries in practice, FRN: P2010WB042700, as the Secretarial Auditors of the Company for a period of 5 years i.e., fY 2025-26 to FY 2029-30, subject to approval of shareholders at 86th Annual General Meeting

COST AUDITOR:

In accordance with the provisions of Section 148 of the Companies Act, 2013 and the Companies (Cost Records and Audit) Rules, 2014, the Company is required to appoint a Cost Auditor to audit the cost records relating to the business of manufacturing of Bulk Drugs and Formulations of the Company. Accordingly, the Board on the recommendation of the Audit Committee had approved the re- appointment of M/s. S. Gupta & Co., Kolkata, Cost & Management Accountants (Firm Registration No. 000020) as Cost Auditors for auditing the cost records of the Company for the financial year ended March 31, 2026.

Pursuant to the provisions of Section 148 of the Companies Act, 2013 read with Rule 14 of the Companies (Audit and Auditor) Rules, 2014 framed thereunder, the remuneration payable to M/s. S. Gupta & Co. as Cost Auditors for the financial year 2025-26 is required to be ratified by the Members of the Company and accordingly, a resolution for the same is being placed before the Members at the 86th Annual General Meeting of the Company for their approval.

Cost records required to be maintained by the company pursuant to the order of the central government are maintained by the Company.

No fraud has been reported by the Cost Auditors of the Company.

SHARE CAPITAL:

The equity shares of your Company continue to be listed and traded on the BSE Limited and National Stock Exchange of India Limited. During the year under review, the Company has not issued shares with differential voting rights or granted any stock options or issued any sweat equity or issued any Bonus Shares. Further, the Company has not bought back any of its securities during the period under review.

ANNUAL RETURN:

The annual return of the company as on March 31, 2025, in terms of the provisions of Section 134(3)(a) of the Act, has been made available on the company''s website https:// https://www.albertdavidindia.com/annualreturn.php

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO:

The details with respect to conservation of energy, technology absorption, foreign exchange earnings and outgo pursuant to Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 framed thereunder, is attached as "Annexure- 2" to this Report.

CORPORATE SOCIAL RESPONSIBILITY (CSR) ACTIVITY:

In compliance with the requirements of Section 135 of the Act, the Company has laid down a CSR Policy. The composition of the Committee, contents of CSR Policy and report on CSR activities carried out during the financial year ended 31st March, 2025 in the format prescribed under the Companies (Corporate Social Responsibility Policy) Rules, 2014 is annexed herewith as "Annexure 3". The CSR policy is available on the Company''s website: https://www.albertdavidindia.com/ policies.php.

Mr. Shirish Gundopant Belapure resigned from CSR Committee w.e.f. 10.03.2025 due to his resignation from Directorship of company w.e.f 10.03.2025 due to his increasing professional commitments.

DIRECTORS AND KEY MANAGERIAL PERSONNEL:

The constitution of the Board of the Company is in accordance with Section 149 of the Company Act, 2013 and Regulation 17 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

> Directors

As on March 31, 2025, The Board of Directors of your Company comprised of 1 Promoter Executive Director, 2 Promoter Non-Executive Directors, 1 Non-Promoter Executive-Director and 4 Non-Executive Independent Directors (till end of 31st March, 2025) including 1 Woman Director. Brief profiles of all Directors of company are available on your company''s website at https://www.albertdavidindia.com/bod.php.

During the F.Y 2024-25, following changes were effected in Board of Directors of the company:-

Mr. Anurag Singhi (DIN: 01807541) has been appointed as a Non-Executive Independent Director of the Company for a period of 5(five) years from 1st April, 2024 to 31st March, 2029, not liable to retire by rotation.

Mr. Naresh Pachisia (DIN: 00233768) has been appointed as a Non-Executive Independent Director of the Company for a period of 5(five) years from 14th November, 2024 to 13th November, 2029, not liable to retire by rotation.

Mr. Shirish Gundopant Belapure (DIN: 02219458), a Non-Executive Independent Director of the Company, resigned from the board of the Company w.e.f 10th March 2025 due to his increasing professional commitments.

On the basis of the written representation received from the Directors, none of the Directors of the Company are disqualified / debarred to act as Director under the provisions of Section 164(2) of the Companies Act, 2013, Rule 14(1) of the Companies (Appointment and Qualifications of Directors) Rules, 2014 and by virtue of any Order of the Ministry of Corporate Affairs, the SEBI or any other Authority.

> Declaration by Independent Directors

In terms of Section 149, 152 read with Schedule IV and other applicable provisions of the Companies Act, 2013 and the Companies (Appointment and Qualifications of Directors) Rules, 2014 (including any statutory modifications or reenactment thereof for the time being in force), the Independent Directors are appointed for a term of five years and are not liable to retire by rotation.

As required under Section 149(7) of the Act, all the Independent Directors of the Company have given declarations that they meet the criteria of independence as laid down in section 149(6) of the Act and Regulation 16(1)(b) and Regulation 25 of Listing Regulations. There has been no change in the circumstances affecting their status as Independent Directors of the Company.

The Independent Directors have confirmed that they have complied with the Company''s Code of Conduct. They have registered their names in the Independent Directors'' Databank.

In the opinion of the Board, they fulfil the conditions of independence as specified in the Act and the SEBI Listing Regulations and are independent of the management. Further, the Board is also of the opinion that all the Independent Directors of the Company are persons of integrity and possess relevant expertise and experience to act as Independent Directors of the Company.

> Familiarization Program undertaken for Independent Director

The Independent Directors are familiarized with the Company, enlightening them of their role, responsibilities and rights, nature of the industry in which the Company operates, business model of the Company etc. as required under Regulation 25(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On appointment, the Independent Director is issued a formal Letter of Appointment setting out in detail, the terms of appointment, duties, responsibilities and expected time commitments. Each newly appointed Independent Director undergoes a formal induction program covering the Company''s operations, marketing, finance and other important aspects. The Company Secretary briefs the Independent Director about their legal and regulatory responsibilities as such Director. They are also explained in detail, the various compliances required from them under the various provisions of the Companies Act, 2013, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Code(s) of Conduct framed by the Company and other relevant/ applicable regulations. The details of familiarization program imparted to Independent Directors of the Company are available on the Company''s website at https://www.albertdavid.ind.ia.. com/policies.php

Key Managerial Personnel

Mr. Arun Kumar Kothari, Executive Chairman, Mr. Umesh Manohar Kunte, Managing Director & CEO, Mr. Ranadeep Bhattacharya, Chief Financial Officer and Mr. Lalit Lohia, Company Secretary & Compliance Officer of the Company are the whole-time Key Managerial Personnel of the Company in terms of section 2(51) and Section 203 of the Companies Act, 2013, as on the date of this report.

Changes in Key Managerial Personnel during the year

The Board has appointed Mr. Lalit Lohia (ACS-23995) as a Company Secretary & Compliance officer of the Company w.e.f 12th August, 2024 in place of Mr. Abhishek Seth (ACS-39671) who resigned w.e.f 2nd June, 2024.

ANNUAL EVALUATION OF THE BOARD, ITS COMMITTEES, AND INDIVIDUAL DIRECTORS:

The Company has devised a Policy for performance evaluation of Independent Directors, Board Committees, the Chairman and other individual Directors which includes criteria for performance evaluation of the Non- Executive Directors and Executive Directors. On the basis of Policy approved by the Board for performance evaluation of Independent Directors, Board Committees and other individual Directors, a process of evaluation was followed by the Board for its own performance and that of its Committees and individual Directors through a structured questionnaire which provides valuable feedback for contribution to the Board, improving Board effectiveness, maximising strengths and highlighting areas for further improvement etc.

In a separate meeting of the Independent Directors, performance of the Chairperson, Non-Independent Directors, the Committees and the Board as a whole was evaluated taking into account the views of the Non- Independent Directors and the same was discussed in the NRC and Board Meeting.

Performance evaluation of Independent Directors is done by the entire Board of Directors (excluding the Directors being evaluated)

The Directors expressed their satisfaction over the evaluation process and the results thereof.

NUMBER OF MEETINGS OF THE BOARD OF DIRECTORS:

During the year, 4 (four) meetings of Board of Directors were held on 13th May, 2024, 9th August 2024, 14th November, 2024 and 12th February, 2025. The details of the Board Meetings with regard to their dates and attendance of each of the Directors thereat have been provided in the Corporate Governance Report.

MEETING OF INDEPENDENT DIRECTORS:

During the year under review, a separate meeting of the Independent Directors of the Company was held on 12th February, 2025, wherein the performance of the Non- Independent Directors and the Board as a whole was evaluated. The Independent Directors at their meeting also assessed the quality, quantity and timeliness of flow of information between the Company''s management and the Board of Directors.

COMMITTEES OF THE BOARD:

The Company has constituted various Board level committees in accordance with the requirements of Companies Act 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, viz.:

> Audit Committee

> Nomination and Remuneration Committee

> Stakeholders'' Relationship/Grievance Committee

> Corporate Social Responsibility Committee

Details of all the above Committees along with their composition, terms of reference and meetings held during the year under review etc. are provided in the Report on Corporate Governance forming part of Annual Report and the same is also available on our company''s website at https://www.albertdavidindia.com/cod.php.

POLICY ON DIRECTORS'' APPOINTMENT AND REMUNERATION:

The Company has a Nomination and Remuneration Policy pursuant to Section 178 of the Companies Act, 2013 envisaging therein, inter-alia, the Company'' policy on appointment and remuneration of Directors, Key Managerial Personnel and Senior Management Personnel. The said Policy is attached as "Annexure-4" to this Report and may also be accessed at the Company''s website at https://www.albertdavidindia.com/policies.php.

WHISTLE BLOWER POLICY/VIGIL MECHANISM:

The Company has established an effective Whistle Blower Policy pursuant to the Companies Act, 2013. The said policy may be referred to at the Company''s website at https://www.albertdavidindia.com/policies.php.

The Whistle Blower Policy aims at ensuring conduct of the affairs of the Company in a fair and transparent manner by adopting the highest standards of professionalism, honesty, integrity and ethical behavior.

A mechanism has been established for employees to report unethical behavior, actual or suspected fraud or violation of the Code of Conduct and ethics directly to the forum. It also provides for adequate safeguards against victimization of employees who avail the mechanism and allows direct access to the Chairman of the Audit Committee in exceptional cases.

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company is committed to providing a safe and conducive work environment to all its employees and associates. The Company has policy on Prevention of Sexual Harassment at Workplace in place. All employees, consultants, trainees, MRs, volunteers, third parties and/ or visitors at all business units or functions of the Company, are covered by the said policy. Adequate workshops and awareness programmes against sexual harassment are conducted across the organisation.

The Company has constituted an Internal Complaints Committee in compliance with the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and is fully compliant of the Committee composition requirements. No complaint of sexual harassment was received during the financial year 20242025. No complaints were pending as at the end of the financial year 2024-2025.

PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS :

Details of loans given, investments made or guarantees given or security provided, if any, as per the provisions of Section 186 of the Act and Regulation 34(3) read with Schedule V of the SEBI Listing Regulations are given in the notes No. 62 forming part of the financial statements provided in this Annual Report.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:

There are no materially significant related party transactions made by the Company with related parties which may have potential conflict of interest with the Company at large. As a matter of policy, your Company carries out transactions with related parties on an arms'' length basis. Statement of these transactions is given at Notes to financial statements.

Accordingly, particulars of contracts or arrangements with related parties referred to in Section 188(1) along with the justification for entering into such contract or arrangement in Form AOC-2 does not form part of this report. The Policy on Materiality of Related Party Transactions and on dealing with Related Party Transactions as approved by the Board is available on the Company''s website and can be accessed at https://www.albertdavidindia.com/policies.php. The Audit Committee reviews all related party transactions on quarterly basis.

PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES:

Disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, is annexed herewith as "Annexure-5".

In accordance with the provisions of Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the names and particulars of the top ten employees in terms of remuneration drawn and of the aforementioned employees form part of the Directors''/ Board''s Report as an annexure. However, in terms of the provisions of Section 136(1) of the Companies Act, 2013 read with the rule, the Directors''/ Board''s Report is being sent to all shareholders/ members of the Company excluding the same. The said information is available for inspection at the registered office of the Company during the working hours. Any shareholder/ member interested in obtaining a copy of the annexure may write to the Company Secretary & Compliance Officer either at the registered office address or by email to adlcorp. secretary@adlindia.in.

CORPORATE GOVERNANCE AND MANAGEMENT DISCUSSION & ANALYSIS:

Corporate Governance Report and Management Discussion and Analysis along with the Independent Auditor''s Compliance Certificate and Certificate on non-disqualification of directors in compliance with SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015 forms part of this Directors Report and also forms part of the Annual Report for F.Y 2024-25.

RISKS & MITIGATING STEPS:

The Company has adopted and implemented a Risk Management Policy after identifying various risk factors which the Company encounters in the course of its business. Appropriate structures are present so that risks are inherently monitored and controlled inter-alia through strict risk mitigating measures. In the opinion of the Board, none of the risks faced by the Company threaten the existence of the Company. Financial risks, the Company is exposed to, are described in the appropriate notes to the financial statements.

The Company has adequate internal control system and procedures for minimization of risks. The risk management procedure is reviewed by the Audit Committee and Board of Directors on a quarterly basis at the time of review of quarterly financial results of the Company.

DIRECTORS'' RESPONSIBILITY STATEMENT:

Pursuant to clause (c) of sub-section (3) and sub-section (5) of Section 134, of the Companies Act, 2013, the Board of Directors of the Company hereby state and confirm that:

i) in the preparation of the annual accounts for the year ended March 31, 2025, the applicable accounting standards had been followed along with proper explanation relating to material departures, if any;

ii) the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on March 31, 2025 and of the profit of the Company for that period ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended March 31, 2025 in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

iv) the Directors had prepared the annual accounts on a ''going concern basis'';

v) the Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively; and

vi) the Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

TRANSFER TO INVESTOR EDUCATION AND PROTECTION FUND (IEPF):

Pursuant to the provisions of the Act, read with IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended, declared dividends which remained unpaid or unclaimed for a period of seven years have been transferred by the Company to the IEPF established by the Central Government.

The above Rules also mandate transfer of underlying shares on which dividends are lying unpaid and unclaimed for a period of seven consecutive years to IEPF through corporate action.

Your Company has sent individual notices and also advertised in the newspapers seeking action from the Members who have not claimed their dividends for seven consecutive years. Thereafter, the Company shall transfer such unpaid or unclaimed dividends and corresponding equity shares of the Company for the financial year ended March 31, 2018, to the IEPF Authority.

Members/claimants whose shares or unclaimed dividends have been transferred to the IEPF Authority''s Demat Account or the Fund, as the case may be, may claim such shares or apply for refund of such dividends, by making an application to the IEPF Authority in Form IEPF-5 available at http://www.iepf.gov.in along with requisite fee, if any, as may be decided by the IEPF Authority from time to time. The Member/claimant can file only one consolidated claim in a financial year as per the IEPF Rules.

Members, therefore, are requested to immediately claim their dividends (and shares referred above), before they are transferred by the Company to the IEPF Authority. Details of shares/shareholders in respect of which dividend has not been claimed are available on the Company''s website at http://albertdavidindia.com/undividend.php. Members are hereby advised to verify their records and claim their dividends in respect of all the earlier seven years, if not already claimed.

The Company has appointed Mr. Lalit Lohia, Company Secretary of the Company as the Nodal Officer for the purpose of IEPF w.e.f 12th August, 2024.

COMPLIANCE WITH SECRETARIAL STANDARDS ON BOARD AND GENERAL MEETINGS:

During the year under review, the Company has endeavoured to comply with the applicable Secretarial Standards to the extent applicable.

Disclosure requirements for certain types of agreements binding listed entities under Regulation 30A(2) of Listing Regulations:

There are no agreements entered into by the shareholders, promoters, promoter group entities, related parties, directors, key managerial personnel, employees of the listed entity or of its holding, subsidiary or associate company, among themselves or with the listed entity or with a third party, solely or jointly, which, either directly or indirectly or potentially or whose purpose and effect is to, impact the management or control of the listed entity or impose any restriction or create any liability upon the listed entity as on the date of notification of clause 5A to Para A of Part A of Schedule III of Listing Regulations.

GENERAL DISCLOSURES:

Your Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:

1. Issue of Equity Shares with differential rights as to dividend, voting or otherwise;

2. Issue of Equity Shares (including Sweat Equity Shares) to employees of your Company, under any scheme;

3. Your Company has not resorted to any buy back of its Equity Shares during the year under review;

4. Your Company does not have any subsidiary/ joint ventures/ associate companies;

5. No significant or material orders were passed by the Regulators or Courts or Tribunals which impact the ''going concern''status and your Company''s operations in future;

6. During the year, there has been no change in the nature of the business of the Company;

7. No proceedings are pending against the Company under the Insolvency and Bankruptcy Code, 2016;

8. There has been no instance where the board has not accepted any of the recommendations of the Audit Committee;

9. No One time settlements with Banks or Financial Institutions were entered during the year.

INDUSTRIAL RELATIONSHIP

Emphasis has been laid on cultivation of healthy human relationship in and outside the Company with prevalence of excellent industrial relationship in all units of the Company, Manufacturing units, Sales Offices, Depots and Corporate Office.

ACKNOWLEDGMENT:

The Board sincerely places on record the support given by Medical Profession, Trade, Shareholders, Company''s Bankers and Stockists, Central and State Government Authorities, Stock Exchanges, CDSL, NSDL and all other Business Associates for the growth of the organization. The Board further expresses its appreciation for the services rendered by the Executives, Officers, Staffs and Workers of the Company at all levels.


Mar 31, 2024

The Directors are pleased to present the 85th Annual Report of the Company and the audited Financial Statements for the financial year ended 31st March, 2024. The PDF version of the Report is also available on the Company''s website at www. albertdavidindia.com/annualreport.php.

SUMMARY OF FINANCIALS OF THE COMPANY:

(Rs. in Lakhs)

Particulars

FY 2023-2024

FY 2022-2023

Revenue from operations

36,246.17

34,156.44

Other Income

5,755.21

1,539.64

Total income

42,001.38

35,696.08

Earnings before Interest, Depreciation, Tax & Amortization

10,443.15

5,973.97

Finance Costs

32.12

45.59

Gross Profit (EBDTA)

10,411.03

5,928.38

Depreciation and Amortization

682.52

854.84

Profit before Tax (PBT)

9,728.53

5,073.54

Tax expense

2,186.52

1,456.05

Profit for the year (PAT)

7,542.01

3,617.49

Other Comprehensive Income

112.45

106.32

Total Comprehensive Income for the year

7,654.46

3,723.81

Retained Earnings - Opening Balance

16,552.87

13,384.38

Add : Profit for the year

7,542.01

3,617.49

Less : Dividend paid on Equity Shares during the year

513.64

513.64

Add : Transfer of Realised Gain on sale of Equity Instrument (net of tax)

259.45

50.93

Add : Other Comprehensive income arising from remeasurement of defined benefit obligation (net of tax)

36.16

13.71

Total Retained Earnings

23,876.85

16,552.87

The Company has prepared the Financial Statements in accordance with the Companies (Indian Accounting Standards) Rules, 2015 prescribed under Section 133 of the Companies Act, 2013 (the "Act")

PERFORMANCE DURING THE YEAR & STATE OF THE COMPANY''S AFFAIRS:

FY 2024 was a comparatively stable year with a comparative business environment, but the team at ADL shown and delivered a better financial performance. We registered annual Revenue from Operations of Rs. 362.46 Crores, delivering 6.12% growth over FY 2023. Profit Before Tax for FY 2024 stood at Rs. 97 Crores, marking a growth of 91% from FY 2023.

Some of the highlights of the operations for the year are:

• Revenue from operations for the year increased by 6.12 % to Rs. 36,246.17 Lakhs as against of Rs. 34,156.44 Lakhs for the last year.

• Profit before Tax (PBT) for the year has grown by 91% to Rs. 9,728.51 Lakhs as against a PBT of Rs. 5,073.54 Lakhs for the last year.

• Tax Provision for the current year amounted to Rs. 2,186.52 Lakhs as against a tax provision of Rs. 1,456.05 Lakhs for the last year.

• Profit after Tax (PAT) before other comprehensive income for the year grew by 108% to Rs. 7,542.01 Lakhs as against a PAT of Rs.3,617.49 Lakhs for the last year.

• Earnings Per Share of Rs. 10/- each works out to Rs. 132.15/- for the year as against Rs. 63.39/- for the last year.

Your Directors are also striving to achieve further growth in sales and better financial performance in the forthcoming years.

DIVIDEND:

Your Directors are pleased to recommend a dividend of Rs. 11.50 per equity share of Rs. 10/- each, i.e. 115% for the FY ended 31st March, 2024, subject to approval of members at the ensuing Annual General Meeting. The Dividend, if approved by the members at the ensuing Annual General Meeting, will be paid to all those equity shareholders of the Company whose names appear in the

Register of Members and/or Register of Beneficial Owners as on the record date and will result into a cash outflow of Rs.656.32 Lakhs.

RESERVES:

During the year under review, no amount was transferred to any of the reserves by the Company.

MATERIAL CHANGES AFFECTING THE COMPANY:

There have been no material changes and commitments in the business operations of the Company affecting the financial position, which has occurred between the end of the financial year of the Company to which the financial statements relate and the date of this report.

DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS:

0 The Company has a system of Internal Audit to take care of the Internal Control systems, effectiveness of its functioning and the workflow of the organization in terms of the approved policies of the Company. Every quarter, the Internal Auditors present their Internal Audit Report along with management''s comments and action taken reports thereon before the Audit Committee of the Company;

0 Your Board has adopted various policies, related to Related PartyTransactions,Whistle Blower Mechanism and other procedures for ensuring the orderly and efficient conduct of business. The Company''s system of Internal Control has been designed to provide a reasonable assurance with regard to the maintenance of proper accounting controls, monitoring of operations, safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and timely preparation of reliable financial information.

0 The Company has ERP suite for a reliable, high-end, comprehensive, disciplined, and integrated business solution.

0 The Company is complying with all the applicable Indian Accounting Standards (Ind AS).The accounting records are maintained in accordance with generally accepted accounting principles in India. This ensures that the financial statements reflect the true and fair financial position of the Company.

DEPOSITS:

During the year under review, your Company has neither accepted/renewed any deposits nor has any outstanding Deposits in terms of Section 73 - 76 of the Companies

Act, 2013 read with Companies (Acceptance of Deposits) Rules, 2014.

AUDITORS & THEIR REPORTS:

STATUTORY AUDITORS:

M/s. L. B. Jha & Co., Chartered Accountants (ICAI Firm Registration No. 301088E), Kolkata, were appointed as the Statutory Auditor of the Company at the 83rd Annual General Meeting held on 9th August, 2022 to hold office from the conclusion of the said meeting till the conclusion of the 88th Annual General Meeting to be held in the year 2027.

They have confirmed that they are not disqualified from continuing as Statutory Auditors of the Company. The Report given by the Statutory Auditors on the Company''s financial statements is enclosed with this Report.

The Statutory Auditors had not reported any fraud under Section 143(12) of the Companies Act, 2013, therefore no detail in the said regard is required to be disclosed under Section 134(3)(ca) of the Companies Act, 2013.

The Notes on financial statements referred to in the Auditors'' Report are self-explanatory and does not call for any further comment. The Auditors'' Report does not contain any qualification, reservation, adverse remark or disclaimer.

SECRETARIAL AUDITOR:

Pursuant to the provisions of Section 204 & 134(3) of the Companies Act, 2013 read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 framed thereunder, the Board had appointed M/s. Vinod Kothari & Co., Practicing Company Secretaries (FRN: P1996WB042300), Kolkata, to undertake Secretarial Audit of the Company for the financial year ended 31st March, 2024 and their Report in the prescribed Form MR - 3 is attached as "Annexure - 1" to this Report.

The Secretarial Audit Report does not contain any qualification, reservation or adverse remark. The Company is in compliance with the Secretarial Standards, specified by the Institute of Company Secretaries of India.

COST AUDITOR:

In accordance with the provisions of Section 148 of the Companies Act, 2013 and the Companies (Cost Records and Audit) Rules, 2014, the Company is required to appoint a Cost Auditor to audit the cost records relating to the business of manufacturing of Bulk Drugs and Formulations of the Company. Accordingly, the Board on the recommendation of the Audit Committee had approved the appointment of M/s. S. Gupta & Co., Kolkata,

Cost & Management Accountants (Firm Registration No. 000020) as Cost Auditors for auditing the cost records of the Company for the financial year ended 31st March, 2025.

Pursuant to the provisions of Section 148 of the Companies Act, 2013 read with Rule 14 of the Companies (Audit and Auditor) Rules, 2014 framed thereunder, the remuneration payable to M/s. S. Gupta & Co. as Cost Auditors for the financial year 2024-25 is required to be ratified by the Members of the Company, and accordingly, a resolution for the same is being placed before the Members at the ensuing Annual General Meeting of the Company for their approval.

Cost records required to be maintained by the company pursuant to the order of the central government are maintained by the Company.

No fraud has been reported by the Cost Auditors of the Company.

SHARE CAPITAL:

The equity shares of your Company continue to be listed and traded on the BSE Limited and National Stock Exchange of India Limited. During the year under review, the Company has not issued shares with differential voting rights or granted any stock options or issued any sweat equity or issued any Bonus Shares. Further, the Company has not bought back any of its securities during the period under review.

ANNUAL RETURN:

The annual return of the company as on 31st March, 2024, in terms of the provisions of Section 134(3)(a) of the Act, has been made available on the company''s website https:// www.albertdavidindia.com/annualreturn.php.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO:

The details with respect to conservation of energy, technology absorption, foreign exchange earnings and outgo pursuant to Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 framed thereunder, is attached as "Annexure- 2" to this Report.

CORPORATE SOCIAL RESPONSIBILITY (CSR) ACTIVITY:

In compliance with the requirements of Section 135 of the Act, the Company has laid down a CSR Policy. The composition of the Committee, contents of CSR Policy and report on CSR activities carried out during the financial year ended 31st March, 2024 in the format prescribed

under the Companies (Corporate Social Responsibility Policy) Rules, 2014 is annexed herewith as "Annexure 3" The CSR policy is available on the Company''s website: https://www.albertdavidindia.com/policies.php.

DIRECTORS AND KEY MANAGERIAL PERSONNEL:

The constitution of the Board of the Company is in accordance with Section 149 of the Company Act, 2013 and Regulation 17 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

0 Directors

As on 31st March, 2024, The Board of Directors of your Company comprised of1 Promoter Executive Director, 2 Promoter Non-Executive Directors, 1 Non - Promoter Executive Director and 5 Independent Directors (till end of 31st March, 2024) / 4 Independent Directors (from 01st April, 2024) including 1 Woman Director.

In accordance with the Articles of Association of the Company, Mr. A.V. Kothari (DIN:- 02572346), Director of the Company, is liable to retire by rotation and who, being eligible, offers himself for reappointment. The Board recommends his reappointment.

Mr. Arindam Sarkar (DIN: 06938957), an Independent Director of the Company, resigned from the board of the Company w.e.f. 9th August, 2023.

Mr. Shourya Sengupta (DIN: 09216561), has been appointed as an Independent Director of the Company for a term of five consecutive years commencing from 1st November, 2023 upto 31st October, 2028, not liable to retire by rotation.

Mr. S.G. Belapure (DIN: 02219458), Independent Director of the Company, who holds office as such upto 13th February, 2024 has re-appointed as an Independent Director of the Company, not liable to retire by rotation, for second term of five consecutive years from 14th February, 2024 to 13th February, 2029.

The Board has appointed Mr. Anurag Singhi (DIN: 01807541) as an Independent Director (Additional, Non-Executive) of the Company w.e.f. 1st April, 2024 in place of Mr. Rajiv Singhi (DIN:00071285) who got retired and ceased to be a Non-Executive Independent Director w.e.f end of day, 31st March, 2024 on completion of second term of Independent Director.

Mr. Hemal Kampani (DIN: 00057715) also got retired and cease to be a Non-Executive Independent Director w.e.f end of day, 31st March, 2024 on

completion of second term of Independent Director

0 Declaration by Independent Directors

In terms of Section 149, 152 read with Schedule IV and other applicable provisions of the Companies Act, 2013 and the Companies (Appointment and Qualifications of Directors) Rules, 2014 (including any statutory modifications or re-enactment thereof for the time being in force), the Independent Directors are appointed for a term of five years and are not liable to retire by rotation.

As required under Section 149(7) of the Act, all the Independent Directors of the Company have given declarations that they meet the criteria of independence as laid down in section 149(6) of the Act and Regulation 16(1)(b) and Regulation 25 of Listing Regulations. There has been no change in the circumstances affecting their status as Independent Directors of the Company.

The Independent Directors have confirmed that they have complied with the Company''s Code of Conduct. They have registered their names in the Independent Directors'' Databank.

In the opinion of the Board, they fulfil the conditions of independence as specified in the Act and the SEBI Listing Regulations and are independent of the management. Further, the Board is also of the opinion that all the Independent Directors of the Company are persons of integrity and possess relevant expertise and experience to act as Independent Directors of the Company.

0 Familiarization Program undertaken for Independent Directors

The Independent Directors are familiarized with the Company, enlightening them of their role, responsibilities and rights, nature of the industry in which the Company operates, business model of the Company etc. as required under Regulation 25(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On appointment, the Independent Director is issued a formal Letter of Appointment setting out in detail, the terms of appointment, duties, responsibilities and expected time commitments. Each newly appointed Independent Director undergoes a formal induction program covering the Company''s operations, marketing, finance and other important aspects. The Company Secretary briefs the Independent Director about their legal and regulatory responsibilities as such Director. They are also explained in detail, the various compliances required from them under the

various provisions of the Companies Act, 2013, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Code(s) of Conduct framed by the Company and other relevant/ applicable regulations. The details of familiarization program imparted to Independent Directors of the Company are available on the Company''s website at https://www.albertdavidindia. com/policies.php

Key Managerial Personnel

Mr. Arun Kumar Kothari, Executive Chairman, Mr. Umesh Manohar Kunte, Managing Director & CEO, Mr. Ranadeep Bhattacharya, Chief Financial Officer and Mr. Abhisek Seth, Company Secretary & Compliance Officer of the Company are the whole-time Key Managerial Personnel of the Company in terms of section 2(51) and Section 203 of the Companies Act, 2013, as on the date of this report.

Changes in Key Managerial Personnel during the year

Mr. A.B. Chakrabartty (FCS - 7184) appointed as Company Secretary & Compliance Officer cum Legal Head effective 4th February, 2023 resigned effective 19th January, 2024, and Mr. Abhishek Seth (ACS-39671) appointed as Company Secretary & Compliance Officer effective 14th March, 2024, has resigned effective 2nd June, 2024.

ANNUAL EVALUATION OF THE BOARD, ITS COMMITTEES, AND INDIVIDUAL DIRECTORS:

The Company has devised a Policy for performance evaluation of Independent Directors, Board Committees, the Chairman and other individual Directors which includes criteria for performance evaluation of the NonExecutive Directors and Executive Directors. On the basis of Policy approved by the Board for performance evaluation of Independent Directors, Board Committees and other individual Directors, a process of evaluation was followed by the Board for its own performance and that of its Committees and individual Directors through a structured questionnaire which provides valuable feedback for contribution to the Board, improving Board effectiveness, maximising strengths and highlighting areas for further improvement etc.

In a separate meeting of the Independent Directors, performance of the Chairperson, Non-Independent Directors, the Committees and the Board as a whole was evaluated taking into account the views of the NonIndependent Directors and the same was discussed in the NRC and Board Meeting.

Performance evaluation of Independent Directors is done by the entire Board of Directors (excluding the Directors

being evaluated)

The Directors expressed their satisfaction over the evaluation process and the results thereof.

NUMBER OF MEETINGS OF THE BOARD OF DIRECTORS:

During the year, 6 (six) meetings of Board of Directors were held on 19th May, 2023, 10th August, 2023, 8th September, 2023, 9th November, 2023, 5th February, 2024 and 14th March, 2024. The details of the Board Meetings with regard to their dates and attendance of each of the Directors thereat have been provided in the Corporate Governance Report.

MEETING OF INDEPENDENT DIRECTORS:

During the year under review, a separate meeting of the Independent Directors of the Company was held on 14th March, 2024, wherein the performance of the NonIndependent Directors and the Board as a whole was evaluated. The Independent Directors at their meeting also assessed the quality, quantity and timeliness of flow of information between the Company''s management and the Board of Directors.

COMMITTEES OF THE BOARD:

The Company has constituted various Board level committees in accordance with the requirements of Companies Act 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, viz.:

0 Audit Committee

0 Nomination and Remuneration Committee

0 Stakeholders'' Relationship/Grievance Committee

0 Corporate Social Responsibility Committee

Details of all the above Committees along with their composition, terms of reference and meetings held during the year under review etc. are provided in the Report on Corporate Governance forming part of Annual Report.

POLICY ON DIRECTORS'' APPOINTMENT AND REMUNER ATION:

The Company has a Nomination and Remuneration Policy pursuant to Section 178 of the Companies Act, 2013 envisaging therein, inter-alia, the Company'' policy on appointment and remuneration of Directors, Key Managerial Personnel and Senior Management Personnel. The said Policy is attached as "Annexure-4" to this Report and may also be accessed at the Company''s website at https://www.albertdavidindia.com/policies.php

WHISTLE BLOWER POLICY/VIGIL MECHANISM:

The Company has established an effective Whistle Blower Policy pursuant to the Companies Act, 2013. The said policy may be referred to at the Company''s website at https://www.albertdavidindia.com/policies.php

The Whistle Blower Policy aims at ensuring conduct of the affairs of the Company in a fair and transparent manner by adopting the highest standards of professionalism, honesty, integrity and ethical behavior.

A mechanism has been established for employees to report unethical behavior, actual or suspected fraud or violation of the Code of Conduct and ethics directly to the forum. It also provides for adequate safeguards against victimization of employees who avail the mechanism and allows direct access to the Chairman of the Audit Committee in exceptional cases.

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company is committed to providing a safe and conducive work environment to all its employees and associates. The Company has policy on Prevention of Sexual Harassment at Workplace in place. All employees, consultants, trainees, MRs, volunteers, third parties and/ or visitors at all business units or functions of the Company, are covered by the said policy. Adequate workshops and awareness programmes against sexual harassment are conducted across the organisation.

The Company has constituted an Internal Complaints Committee in compliance with the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and is fully compliant of the Committee composition requirements. One complaint of sexual harassment was received and the same was disposed of during the financial year 2023-2024. No complaints were pending as at the end of the financial year 2023-2024.

PARTICULARS OF LOANS, GUARANTEES AND INVESTM ENS :

Details of loans given, investments made or guarantees given or security provided, if any, as per the provisions of Section 186 of the Act and Regulation 34(3) read with Schedule V of the SEBI Listing Regulations are given in the notes forming part of the financial statements provided in this Annual Report.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:

There are no materially significant related party transactions made by the Company with related parties which may have potential conflict of interest with the Company at large. As a matter of policy, your Company carries out transactions with related parties on an arms'' length basis. Statement of these transactions is given at Notes to financial statements.

Accordingly, particulars of contracts or arrangements with related parties referred to in Section 188(1) along with the justification for entering into such contract or arrangement in Form AOC-2 does not form part of this report. The Policy on Materiality of Related Party Transactions and on dealing with Related Party Transactions as approved by the Board is available on the Company''s website and can be accessed at https://www.albertdavidindia.com/policies.php. The Audit Committee reviews all related party transactions on quarterly basis.

PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES:

Disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, is annexed herewith as "Annexure-5".

In accordance with the provisions of Rule 5(2) of the Companies (Appointment and Remuneration ofManagerial Personnel) Rules, 2014, the names and particulars of the top ten employees in terms of remuneration drawn and of the aforementioned employees form part of the Directors'' / Board''s Report as an annexure. However, in terms of the provisions of Section 136(1) of the Companies Act, 2013 read with the rule, the Directors''/ Board''s Report is being sent to all shareholders/ members of the Company excluding the same. The said information is available for inspection at the registered office of the Company during the working hours. Any shareholder/ member interested in obtaining a copy of the annexure may write to the Company Secretary & Compliance Officer either at the registered office address or by email to adlcorp. secretary@adlindia.in

CORPORATE GOVERNANCE AND MANAGEMENT DISCUSSION & ANALYSIS:

A separate Report on Corporate Governance and Management Discussion and Analysis forms part of the Annual Report along with the Auditor''s Certificate in

compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

RISKS & MITIGATING STEPS:

The Company has adopted and implemented a Risk Management Policy after identifying various risk factors which the Company encounters in the course of its business. Appropriate structures are present so that risks are inherently monitored and controlled inter-alia through strict risk mitigating measures. In the opinion of the Board, none of the risks faced by the Company threaten the existence of the Company. Financial risks, the Company is exposed to, are described in the appropriate notes to the financial statements.

The Company has adequate internal control system and procedures for minimization of risks. The risk management procedure is reviewed by the Audit Committee and Board of Directors on a quarterly basis at the time of review of quarterly financial results of the Company.

DIRECTORS'' RESPONSIBILITY STATEMENT:

Pursuant to clause (c) of sub-section (3) and sub-section

(5) of Section 134, of the Companies Act, 2013, the Board of Directors of the Company hereby state and confirm that:

i) in the preparation of the annual accounts for the year ended 31st March, 2024, the applicable accounting standards had been followed along with proper explanation relating to material departures, if any;

ii) the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on 31st March, 2024 and of the profit of the Company for that period ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended 31st March, 2024 in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

iv) the Directors had prepared the annual accounts on a ''going concern basis'';

v) the Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively; and

vi) the Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

TRANSFER TO INVESTOR EDUCATION AND PROTECTION FUND (IEPF):

Pursuant to the provisions of the Act, read with IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended, declared dividends which remained unpaid or unclaimed for a period of seven years have been transferred by the Company to the IEPF established by the Central Government.

The above Rules also mandate transfer of underlying shares on which dividends are lying unpaid and unclaimed for a period of seven consecutive years to IEPF through corporate action.

Your Company has sent individual notices and also advertised in the newspapers seeking action from the Members who have not claimed their dividends for seven consecutive years. Thereafter, the Company shall transfer such unpaid or unclaimed dividends and corresponding equity shares of the Company for the financial year ended 31st March, 2017, to the IEPF Authority.

Members/claimants whose shares or unclaimed dividends have been transferred to the IEPF Authority''s Demat Account or the Fund, as the case may be, may claim such shares or apply for refund of such dividends, by making an application to the IEPF Authority in Form IEPF-5 available at http://www.iepf.gov.in along with requisite fee, if any, as may be decided by the IEPF Authority from time to time. The Member/claimant can file only one consolidated claim in a financial year as per the IEPF Rules.

Members, therefore, are requested to immediately claim their dividends (and shares referred above), before they are transferred by the Company to the IEPF Authority. Details of shares/shareholders in respect of which dividend has not been claimed are available on the Company''s website at http://albertdavidindia.com/undividend.php. Members are hereby advised to verify their records and claim their dividends in respect of all the earlier seven years, if not already claimed.

The Company has appointed Mr. Abhisekh Seth, Company Secretary of the Company as the Nodal Officer for the purpose of IEPF (since resigned effective 2nd June, 2024).

COMPLIANCE WITH SECRETARIAL STANDARDS ON BOARD AND GENERAL MEETINGS:

During the year under review, the Company has

endeavoured to comply with the applicable Secretarial Standards to the extent applicable.

Disclosure requirements for certain types of agreements binding listed entities under Regulation 30A(2) of Listing Regulations:

There are no agreements entered into by the shareholders, promoters, promoter group entities, related parties, directors, key managerial personnel, employees of the listed entity or of its holding, subsidiary or associate company, among themselves or with the listed entity or with a third party, solely or jointly, which, either directly or indirectly or potentially or whose purpose and effect is to, impact the management or control of the listed entity or impose any restriction or create any liability upon the listed entity as on the date of notification of clause 5A to Para A of Part A of Schedule III of Listing Regulations.

GENERAL DISCLOSURES:

Your Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:

1. Issue of Equity Shares with differential rights as to dividend, voting or otherwise;

2. Issue of Equity Shares (including Sweat Equity Shares) to employees of your Company, under any scheme;

3. Your Company has not resorted to any buy back of its Equity Shares during the year under review;

4. Your Company does not have any subsidiary/ joint ventures/ associate companies;

5. No significant or material orders were passed by the Regulators or Courts or Tribunals which impact the ''going concern''status and your Company''s operations in future;

6. During the year, there has been no change in the nature of the business of the Company;

7. No proceedings are pending against the Company under the Insolvency and Bankruptcy Code, 2016;

8. There has been no instance where the board has not accepted any of the recommendations of the Audit Committee;

9. No One time settlements with Banks or Financial Institutions were entered during the year.

INDUSTRIAL RELATIONSHIP:

Emphasis has been laid on cultivation of healthy human relationship in and outside the Company with prevalence

of excellent industrial relationship in all units of the Company, Manufacturing units, Sales Offices, Depots and Corporate Office.

ACKNOWLEDGMENT:

The Board sincerely places on record the support given by Medical Profession, Trade, Shareholders, Company''s Bankers and Stockists, Central and State Government Authorities, Stock Exchanges, CDSL, NSDL and all other Business Associates for the growth of the organization. The Board further expresses its appreciation for the services

rendered by the Executives, Officers, Staffs and Workers of the Company at all levels.


Mar 31, 2018

The Directors have pleasure in presenting their 79th Annual Report on the business and operations of the Company and the accounts for the financial year ended 31st March, 2018.

FINANCIAL HIGHLIGHTS/PERFORMANCE OF THE COMPANY (Rs. In Lacs)

2017-2018

2016-2017

Revenue from operations

28899.33

30646.57

Other Income

890.83

762.49

Total Income from continuing operations

29790.16

31409.06

Earning before Interest, Depreciation, Tax & Amortization

3063.37

3548.95

Finance Costs

85.88

73.75

Gross Profit (EBDTA)

2977.49

3475.20

Depreciation and Amortization

823.10

751.66

Profit before exceptional and extraordinary items and tax

2154.39

2723.54

Exceptional Items

-

-

Extraordinary Items

-

-

Profit before Tax (PBT)

2154.39

2723.54

Tax expense

806.17

1017.37

Net Profit for the period from continuing operations

1348.22

1706.17

Profit /(Loss) for the period from discontinued operations

(364.14)

(110.66)

Profit for the period

Other Comprehensive Income:

984.08

1595.51

From continuing operations

(309.04)

(139.10)

From discontinued operations

(3.87)

(3.24)

Total Comprehensive Income for the period

671.17

1453.17

Retained Earnings - Opening Balance

4487.22

4134.05

Add: Profit for the year

984.08

1595.51

Less: Dividend paid on Equity Shares during the year

313.91

-

Less: Corporate Dividend Tax paid during the year

63.90

-

Other Comprehensive Income:

(312.91)

(142.34)

Transfer to General Reserve

-

1100.00

Balance carried forward to Balance Sheet

4780.58

4487.22

BRIEF DESCRIPTION OF THE COMPANY''S WORKING DURING THE YEAR/ STATE OF COMPANY''S AFFAIRS:

During the year under review, your Company achieved Net Sales of Rs.28710.87 Lacs and recorded a Gross Profit of Rs.2977.49 Lacs compared to previous year''s Net Sales of Rs. 30479.75 Lacs and Gross Profit of Rs.3475.20 Lacs from continuing operations. There was after tax loss from discontinued operations of Rs.364.14 Lacs and Rs.110.66 Lacs during the year 2017-18 and 2016-17, respectively.

During the current financial year, your Company plans to further strengthen its operations by relooking at and strengthening its product portfolio as well as operating structure. Financial year 2017-18 was a difficult year for the Indian Pharmaceutical industry. In the wake of implementation of Goods & Service Tax (GST) the industry was badly impacted, especially on account of destocking of inventory leading to lowest growth in the last five years.

Your Directors are hopeful of further growth in sales and better financial performance during the current year.

DIVIDEND:

The Board of Directors of your Company is pleased to recommend payment of dividend of Rs.5.50/- per equity share of Rs.10/- each for the financial year ended 31st March, 2018 amounting to Rs.378.43 Lacs (inclusive of dividend distribution tax of Rs. 64.52 Lacs).

TRANSFER TO RESERVES:

Your Board proposes to keep the entire retained earnings in Profit & Loss Account.

CHANGE IN THE NATURE OF BUSINESS, IF ANY:

During the year under review, there has been no change in the nature of business of the Company.

MATERIAL CHANGES AND COMMITMENTS DURING THE YEAR:

During the year the Company had to shut down the operations of Mandideep Unit of the Company with effect from 1st January, 2018 as it had become commercially unviable.

MATERIAL CHANGES AND COMMITMENTS AFTER THE BALANCE SHEET DATE:

There were no material changes and commitments in the business operations of the Company affecting the financial position of the Company which have occurred between the end of the financial year of the Company to which the financial statements relate and the date of this report.

DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY''S OPERATIONS IN FUTURE:

There were no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Company''s operations in future.

DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS:

1. The Company has appointed Internal Auditors to observe the Internal Controls who regularly monitors if the workflow of the organization is being done through the approved policies of the Company. In every quarter during the approval of Financial Results, Internal Auditors present the Internal Audit Report and Management comments on the Internal Audit observations;

2. The Board of Directors of the Company has adopted various policies like Related Party Transaction Policy, Whistle Blower Policy and other procedures for ensuring the orderly and efficient conduct of its business. The Company''s system of internal control has been designed to provide a reasonable assurance with regard to maintaining of proper accounting controls, monitoring of operations, safeguarding of its assets, prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and timely preparation of reliable financial information.

3. The Company has installed ERP suite for a reliable, high end, comprehensive, disciplined and integrated business solution.

DEPOSITS:

Your Company has not accepted any Fixed Deposits under Chapter V of the Companies Act, 2013 during the Financial Year and as such, no amount on account of Principal or Interest on Deposits from Public was outstanding as on 31st March, 2018.

STATUTORY AUDITORS:

M/s. Basu Chanchani & Deb, Chartered Accountants (Firm Registration No. 304049E), Kolkata had been appointed as the Statutory Auditors of the Company by the members in their AGM held on 12th September, 2017 till the conclusion of fifth consecutive AGM of the Company to be held in the year 2022 (subject to ratification by the members at every AGM) . In view of the amendment made to Section 139 of the Companies Act, 2013 vide Companies (Amendment) Act, 2017 which is effective from 7th May, 2018, annual ratification of appointment of statutory auditors have been done away with.

Accordingly M/s. Basu Chanchani & Deb, Chartered Accountants shall continue to be the Statutory Auditors of the Company till the conclusion of AGM to be held in the year 2022 and their appointment shall not be subject to ratification by the members on an annual basis.

DETAILS OF SUBSIDIARY/JOINT VENTURES/ASSOCIATE COMPANIES:

The Company does not have any subsidiary/joint ventures/associate companies.

AUDITORS'' REPORT:

The Auditors'' Report to the shareholders on the financial statements of the Company for the financial year ended 31st March, 2018 does not contain any qualification, reservation or adverse remark or disclaimer.

SECRETARIAL AUDIT:

The provisions of Section 204 of the Companies Act, 2013 mandates Secretarial Audit of the Company for the financial year 2017-2018 by a Company Secretary in Practice and accordingly the Board had appointed M/s. MKB & Associates, Practicing Company Secretaries (FRN: P2010WB042700) as Secretarial Auditor to conduct secretarial audit of the Company for the financial year ended 31st March, 2018 and their Report in Form MR-3 is attached as "Annexure - 1" to this Annual Report.

There are no qualifications in the Secretarial Audit Report.

COST AUDIT :

In accordance with the provisions of Section 148 of the Companies Act, 2013 and the Companies (Cost Records and Audit) Rules, 2014, the Company is required to appoint a Cost Auditor to audit the cost records relating to the business of manufacturing of Bulk Drugs and Formulations business of the Company. Accordingly, the Board had appointed M/s. S. Gupta & Co., Kolkata, Cost & Management Accountants (Firm Registration No. 000020) as Cost Auditors for auditing the cost records of the Company for the financial year ended 31st March, 2018.

Pursuant to the provisions of Section 148 of the Companies Act, 2013 read with Rule 14 of the Companies (Audit and Auditor) Rules, 2014, the remuneration payable to M/s. S. Gupta & Co., Cost Auditor, for the year 2018-19, is required to be ratified by the Members of the Company, and accordingly, a resolution for the same is being placed before the Members at the ensuing Annual General Meeting.

SHARE CAPITAL:

There was no change in the Share Capital of the Company during the year.

EXTRACT OF THE ANNUAL RETURN:

Extract of the Annual Return in Form MGT - 9 pursuant to the provisions of Section 92 the Companies Act, 2013 and Rule 12 of the Companies (Management and Administration) Rules, 2014 is enclosed as "Annexure - 2" to this Report.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO:

Information with respect to conservation of energy, technology absorption, foreign exchange earnings and outgo pursuant to Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 is attached as "Annexure - 3" to this Annual Report.

CORPORATE SOCIAL RESPONSIBILITY ACTIVITIES:

The Board of Directors of the Company on the recommendation of the CSR Committee has adopted a CSR Policy which inter-alia states the CSR activities to be undertaken by the Company. The Policy may be referred at the Company''s official website at http://albertdavidindia.com/investor/sh_information/policy/Corporate%20Social%20 Responsibility%20Policy.pdf.

The Company has spent Rs.33.58 Lacs in discharging its corporate social responsibility obligation during the year. In terms of section 135 of the Companies Act, 2013, an amount of Rs.41.69 Lacs was due to be spent. The balance amount of Rs.8.11 Lacs has been carried forward to the next year, as suitable projects/programmes could not be identified for carrying out the activities as per CSR Policy of the Company.

Details about the Company''s CSR Policy and initiatives undertaken by the Company during the financial year 2017-18 are outlined in the Report on CSR Activities attached as "Annexure - 4" to this Annual Report.

DIRECTORS AND KEY MANAGERIAL PERSONNEL:

(a) Declaration by Independent Directors

All the Independent Directors have submitted their declaration of independence pursuant to Section 149(7) of the Companies Act, 2013 stating that they meet the criteria of independence as laid down in section 149(6) of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

(b) Familiarization Programme undertaken for Independent Directors

The Independent Directors are familiarized with the Company, their roles, rights and responsibilities in the Company, nature of the industry in which the Company operates, business model of the Company etc. pursuant to Regulation 25(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On appointment, the Independent Director is issued a Letter of Appointment setting out in detail, the terms of appointment, duties, responsibilities and expected time commitments. Each newly appointed Independent Director is taken through a formal induction program on the Company''s operations, marketing, finance and other important aspects. The Company Secretary briefs the Director about their legal and regulatory responsibilities as a Director. The Directors are also explained in detail the various compliances required from him as a Director under the various provisions of the Companies Act, 2013, SEBI (LODR) Regulations, 2015, SEBI (Prohibition of Insider Trading) Regulations, 2015, the Code of Conduct of the Company and other relevant regulations. The details of familiarization program is available on the Company''s website under the weblink: http://albertdavidindia.com/investor/sh_information/policy/familiarisation_program.pdf

(c) Non-Independent Director

In accordance with the Articles of Association of the Company, Mrs. Prabhawati Devi Kothari (DIN - 00051860), Director of the Company, is liable to retire by rotation and being eligible, offers herself for re-appointment. The Board recommends her re-appointment with a view to avail her valuable advice and wise counsel.

Brief profile of the Director(s) seeking appointment/ re-appointment, and other information as required under the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Secretarial Standards-2 forms part of the Notice of AGM forming part of this Annual Report.

None of the Directors of the Company is disqualified to act as Directors, as specified in section 164(2) of the Companies Act, 2013 and Rule 14(1) of the Companies (Appointment and Qualification of Directors) Rules, 2014.

(d) Change in Directorship

During the year under review, Dr. Karunamay Lahiri vacated his office of directorship of the Company pursuant to Section 167(1)(a) of the Companies Act, 2013 w.e.f. 12th October, 2017.

On the recommendation of the Nomination and Remuneration Committee of the Company, the Board of Directors in their meeting held on 28th March, 2018 had re-appointed Mr. Arun Kumar Kothari as Wholetime Director designated as Executive Chairman with effect from 1st April, 2018. The Board of Directors have in the said meeting also appointed Mr. Tarminder Singh Parmar as an Additional Director as well as Managing Director & CEO of the Company with effect from 1st April, 2018. Mr. Hari Prasad Kabra, Executive Director of the Company has retired from 1st April, 2018.

Your Directors wish to place their sincere appreciation for the contribution made by Mr. Hari Prasad Kabra and Dr. Karunamay Lahiri during their association with the Company. Your Board also recommends the appointment of:

i) Mr. Arun Kumar Kothari as Wholetime Director designated as Executive Chairman for a term of 3 (three) years with effect from 1st April, 2018;

ii) Mr. Tarminder Singh Parmar as Managing Director & CEO for a term of 5 (five) years with effect from 1st April, 2018.

(e) Key Managerial Personnel

Mr. Arun Kumar Kothari, Executive Chairman, Mr. Tarminder Singh Parmar, Managing Director & CEO, Mr. Subhash Chandra Shah, Vice President (Finance) & CFO and Dr. Indrajit Dhar, Associate Vice President (Accounts & Taxation)-cum-Company Secretary are the Whole-time Key Managerial Personnel of the Company as per Section 203 of the Companies Act, 2013.

ANNUAL EVALUATION OF BOARD''S PERFORMANCE:

Pursuant to the requirements of the Companies Act, 2013 and the SEBI Listing Regulations, evaluation of each member of the Board is done on an annual basis. The evaluation is done by the Board (excluding presence of the member under evaluation), the Nomination and Remuneration Committee and the Independent Directors with specific focus on the performance and effective functioning of the Board/ Committees and individual Directors. A structured questionnaire was prepared after taking into consideration inputs received from the Directors, covering various aspects of the Board''s functioning such as adequacy of the composition of the Board and its Committees, Board culture, execution and performance of specific duties, obligations and governance.

a) Criteria for evaluation of the Board of Directors as a whole

i. Frequency of meetings;

ii. Length of meetings;

iii. Administration of meeting;

iv. Number of Committees and their roles;

v. Flow of information to Board members and between Board members;

vi. The quality and quantity of information; and

vii. Disclosure of information to the stakeholders.

b) Criteria for evaluation of individual Directors

i. Commitment to fulfillment of the Director''s obligations and fiduciary responsibilities;

ii. Attendance and contribution at Board/Committee meetings;

iii. Ability to contribute by introducing best practices to address top management issues;

iv. Monitoring management performance and development;

v. Participation in long term strategic planning;

vi. Ability to contribute and monitor corporate governance practices;

vii. Statutory compliance & Corporate governance;

viii. Time spent by each of the members;

ix. Core competencies; and

x. Guiding strategy.

The Directors express their satisfaction over the evaluation process and results thereof.

NUMBER OF MEETINGS OF THE BOARD OF DIRECTORS:

During the financial year ended 31st March, 2018 eight Board Meetings were held i.e. on 30th May, 2017, 1st August, 2017, 12th September, 2017, 30th October, 2017, 12th December, 2017, 26th December, 2017, 12th February, 2018 and 28th March, 2018. The maximum time gap between any two meetings was less than one hundred and twenty days as stipulated under SEBI (LODR) Regulations, 2015. Details of the Board meetings held during the financial year have been furnished in the Corporate Governance Report forming part of this Annual Report.

MEETING OF INDEPENDENT DIRECTORS:

During the year under review, a seperate meeting of Independent Directors was held on 28th March, 2018 wherein the performance of the Non-Independent Directors and the Board as a whole was reviewed. The Independent Directors at their meeting also assessed the quality, quantity and timeliness of flow of information between the Company''s management and the Board of Directors of the Company.

COMMITTEES OF THE BOARD:

The Company has constituted/re-constituted various Board level committees in accordance with the requirements of the Companies Act 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Details of all the Committees along with their composition and meetings held during the year under review are provided in the Report on Corporate Governance forming part of this Annual Report.

AUDIT COMMITTEE:

The Audit Committee presently comprises of Mr. Rajiv Singhi, Chairman, Mr. Arun Kumar Kothari, Mr. Hemal Kampani and Mr. Arindam Sarkar as Members. The terms of reference of the Audit Committee and the particulars of meetings held and attendance thereat are mentioned in the Report on Corporate Governance forming part of the this Annual Report.

NOMINATION AND REMUNERATION COMMITTEE:

The Nomination and Remuneration Committee presently comprises of Mr. Rajiv Singhi, Chairman, Mr. Arun Kumar Kothari, Mrs. Prabhawati Devi Kothari, Mr. Hemal Kampani and Mr. Arindam Sarkar as Members. The terms of reference of the Nomination and Remuneration Committee and the particulars of meetings held and attendance thereat are mentioned in the Report on Corporate Governance forming part of this Annual Report.

COORPORATE SOCIAL RESPONSIBILITY COMMITTEE:

The Corporate Social Responsibility Committee presently comprises of Mr. Arun Kumar Kothari, Chairman, Mr. Tarminder Singh Parmar and Dr. Amal Kumar Bhattacharya as Members. The terms of reference of the Corporate Social Responsibility Committee and the particulars of meetings held and attendance thereat are mentioned in the Report on Corporate Governance forming part of this Annual Report.

STAKEHOLDERS'' RELATIONSHIP/GRIEVANCE COMMITTEE:

The Stakeholders'' Relationship/Grievance Committee presently comprises of Mr. Hemal Kampani, Chairman, Mr. Arun Kumar Kothari, Mrs. Prabhawati Devi Kothari and Mr. Tarminder Singh Parmar as Members. The terms of reference of the Stakeholders'' Relationship/Grievance Committee and the particulars of meetings held and attendance thereat are mentioned in the Report on Corporate Governance forming part of this Annual Report.

POLICY ON DIRECTORS'' APPOINTMENT AND REMUNERATION:

The Company has a Nomination and Remuneration Policy pursuant to Section 178 of the Companies Act, 2013 stating therein the Company'' policy on Directors'' appointment and remuneration. The said Policy is attached as "Annexure - 5" to this Annual Report. It may also be accessed at the Company''s website at http://albertdavidindia. com/investor/sh_information/policy/nr_policy.pdf

WHISTLE BLOWER POLICY/VIGIL MECHANISM:

The Company has established an effective Whistle Blower Policy pursuant to the Companies Act, 2013 and SEBI Listing Regulations, 2015. The said policy may be referred to at the Company''s website at the following web link http://albertdavidindia.com/ investor/sh_information/policy/whistle_blower.pdf

The Whistle Blower Policy aims at conducting the affairs of the Company in a fair and transparent manner by adopting the highest standards of professionalism, honesty, integrity and ethical behavior. All permanent employees of the Company are covered under the Whistle Blower Policy.

A mechanism has been established for employees to report concerns about unethical behavior, actual or suspected fraud or violation of Code of Conduct and Ethics. It also provides for adequate safeguards against the victimization of employees who avail of the mechanism and allows direct access to the Chairman of the Audit Committee in exceptional cases.

DISCLOSURE AS REQUIRED UNDER SECTION 22 OF SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company as an organization is committed to provide a healthy environment to all employees and thus does not tolerate any discrimination and/or harassment in any form. The Company has in place a Prevention of Sexual Harassment Policy in line with the requirement of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. The Company has set up Internal Complaint Committee which is chaired by a female employee of the Company. No complaints were received during the financial year 2017-2018.

PARTICULARS OF LOANS, GURANTEES AND INVESTMENTS:

Details of loans, guarantees and investments covered under Section 186 of the Companies Act, 2013 form part of the Note No. 57 to the Financial Statements provided in this Annual Report.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:

A Related Party Transaction Policy has been formulated by the Board of Directors for determining the materiality of transactions with related parties and dealing with them. The said policy may be referred to at the Company''s website at http://albertdavidindia.com/investor/sh_information/policy/related_party_transaction.pdf The Audit Committee reviews all related party transactions on quarterly basis.

All contracts or arrangements with related parties, entered into or modified during the financial year, within the meaning of Section 188(1) of Companies Act, 2013 (the Act) were in the ordinary course of business and on an arm''s length basis and in compliance with the applicable provisions of the Companies Act, 2013 and the Listing Regulations. There are no material contracts or arrangements entered into by the Company during the year with Related Parties. There are no materially significant related party transactions entered into by the Company with promoters, directors, key managerial personnel or other designated persons or related party as per definition contained u/s 2(76) of the Act,which may have a potential conflict with the interest of the Company at large. Accordingly, the disclosure of Related Party Transactions as required under Section 134(3)(h) of the Companies Act, 2013 read with Rule 8 of the Companies (Accounts) Rules, 2014 in Form AOC-2 is not applicable.

Your Directors draw attention of the members to Note No. 46 to the financial statement which set out related party disclosures.

PARTICULARS OF EMPLOYEES:

Details of the ratio of the remuneration of each Director to the median remuneration of the employees of the Company and other details pursuant to Section 197(12) of the Companies Act, 2013 and Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 (as amended) is attached as "Annexure - 6" to this Annual Report.

Disclosure pertaining to Remuneration and Statement showing the names of top ten employees in terms of remuneration drawn, as required under Section 197(12) of the Act and Rule 5(2) & 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 (as amended) is attached as "Annexure-7" to this Annual Report.

CORPORATE GOVERNANCE AND MANAGEMENT DISCUSSION & ANALYSIS:

A separate report on Corporate Governance and Management Discussion and Analysis is annexed as part of the Annual Report along with the Auditor''s Certificate in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

RISKS & MITIGATING STEPS :

The Company has adopted and implemented a Risk Management Policy after identifying various risks which the Company encounters in the course of its business. Appropriate structures are present so that risks are inherently monitored and controlled inter alia through strict quality assurance measures. In the opinion of the Board, none of the risks faced by the Company threaten the existence of the Company. Financial risks the Company is exposed to are described in the appropriate notes to the financial statements.

The Company has adequate internal control systems and procedures to combat risks. The risk management procedure is reviewed by the Audit Committee and Board of Directors on a quarterly basis at the time of review of quarterly financial results of the Company.

DIRECTORS'' RESPONSIBILITY STATEMENT:

Pursuant to clause (c) of sub-section (3) of Section 134 and Section 134(5) of the Companies Act, 2013, the Board of Directors of the Company hereby state and confirm that :

i) in the preparation of the annual accounts for the year ended 31st March, 2018, the applicable accounting standards had been followed along with proper explanation relating to material departures, if any;

ii) the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on 31st March, 2018 and of the profit of the Company for that period;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended 31st March, 2018 in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

iv) the Directors had prepared the annual accounts on a ''going concern basis'';

v) the Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively; and

vi) the Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

TRANSFER TO INVESTOR EDUCATION & PROTECTION FUND (IEPF):

Pursuant to applicable provisions of the Companies Act, 2013 ("the Act") read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 ("the Rules"), all unpaid or unclaimed dividends are required to be transferred by the Company to the Investor Education and Protection Fund (IEPF) established by the Central Government, after completion of seven years. Further, according to the said Act and Rules, the shares in respect of which dividend has not been paid or claimed by the Members for seven consecutive years or more shall also be transferred to the demat account of the IEPF Authority.

Your Company had sent individual notices and also advertised in the newspapers seeking action from the Members who had not claimed their dividends for seven consecutive years or more. Accordingly, the Company had transferred such unpaid or unclaimed dividends and corresponding shares for the Financial Year ended 31st March, 2010. Members/claimants whose shares or unclaimed dividends, have been transferred to the IEPF Demat Account or the Fund, as the case may be, may claim such shares or apply for refund by making an application to the IEPF Authority in Form IEPF-5 (available at http://www.iepf.gov.in) along with requisite fee, if any, as may be decided by the IEPF Authority from time to time. The Member/claimant can file only one consolidated claim in a Financial Year as per the IEPF Rules.

Your Company will be transferring the Dividend and corresponding Shares for the Financial Year ended 31st March, 2011 on or before 10th September, 2018. Accordingly, Members are requested to ensure that they claim the dividends and shares referred above, before they are transferred to the said IEPF Authority. Details of shares/shareholders in respect of which dividend has not been claimed, are provided on our website at https://www.albertdavidindia.com/ undividend.php and http://www.albertdavidindia.com/notice_other.php The shareholders are therefore advised to verify their records and claim their dividends of all earlier seven years, if not already claimed.

IMPLEMENTATION OF IND-AS:

Your Company has adopted Ind AS during the year retrospectively from 1st April, 2016 pursuant to a notification dated 16th February, 2015, issued by the Ministry of Corporate Affairs, notifying the Companies (Indian Accounting Standard) Rules, 2015. Your Company has published Ind AS Financials for the year ended 31st March, 2018 along with comparable as on 31st March, 2017 and Opening Statement of Assets and Liabilities as on 1st April, 2016. Your Company has shared all four quarters re-stated Ind AS Profit and Loss Statement with Investors along with quarterly results for comparison.

GOODS AND SERVICES TAX (GST):

The Goods and Services Tax (GST) is a landmark reform which will have a lasting impact on the economy and on businesses. Implementation of a well-designed GST model that applies to the widest possible base at a low rate can provide stimulus to the business and contribute to the Hon''ble Prime Minister''s mission of ''Make in India''. Your Company has successfully implemented and migrated to GST with effect from 1st July, 2017 and required changes across IT systems, Supply Chain and Operations have been made keeping in mind the sweeping changes that GST has brought in.

COMPLIANCE WITH SECRETARIAL STANDARDS ON BOARD AND GENERAL MEETINGS:

During the Financial Year, your Company has complied with applicable Secretarial Standards issued by the Institute of Company Secretaries of India.

LISTING WITH STOCK EXCHANGES:

Your Company''s Shares are listed with BSE Limited and National Stock Exchange of India Limited and the Company has paid the Listing Fees to the said Stock Exchanges on time.

GENERAL DISCLOSURES:

Your Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:

1. Issue of Equity Shares with differential rights as to dividend, voting or otherwise;

2. Issue of Equity Shares (including Sweat Equity Shares) to employees of your Company, under any scheme;

3. Your Company has not resorted to any buy back of its Equity Shares during the year under review

4. Your Company does not have any subsidiaries;

5. No significant or material orders were passed by the Regulators or Courts or Tribunals which impact the going concern status and your Company''s operations in future.

ACKNOWLEDGMENT:

Your Board sincerely places on record the support extended by the Medical Profession, Trade, Shareholders, Company''s Bankers and Stockists, Central and State Government Authorities, Stock Exchanges, CDSL, NSDL and all other Business Associates for the growth of the organization. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

Registered Office: For and on behalf of the

D - Block, 3rd Floor, Board of Directors Gillander House,

Netaji Subhas Road,

Kolkata - 700 001. A. K. Kothari

CIN: L51109WB1938PLC009490 Executive Chairman

Dated: 29th May, 2018 Din: 00051900


Mar 31, 2016

TO THE SHAREHOLDERS

Ladies & Gentlemen,

The Directors have pleasure in presenting their 77th Annual Report on the business and operations of the Company and the accounts for the financial year ended 31st March, 2016.

FINANCIAL HIGHLIGHTS/PERFORMANCE OF THE COMPANY :

(Rs. in Lacs)

2015-2016

2014-2015

Revenue from operations/Net Sales

32123.52

32086.28

Earning before Interest, Depreciation, Tax & Amortization [EBIDTA]

3105.46

3658.38

Other Income

196.61

179.59

Finance Costs

181.09

269.62

Gross Profit (EBDTA)

3120.98

3568.35

Depreciation and Amortization

899.87

1541.46

Profit Before exceptional and extraordinary items and tax

2221.11

2026.89

Exceptional items

4080.75

—

Profit Before extraordinary items and tax

6301.86

2026.89

Extraordinary items

—

—

Profit Before Tax [PBT]

6301.86

2026.89

Tax expense including for earlier years

1502.27

656.86

Net Profit after Tax [PAT]

4799.59

1370.03

Balance of Profit brought forward from previous year

571.58

529.34

Less : Fixed Assets adjusted for over-aged assets (Net of deferred tax)

(21.16)

—

Surplus available for appropriation

5350.01

1899.37

Appropriations :

Interim Dividend

313.91

313.89

Tax on Dividend

63.90

63.90

Transfer to General Reserve

4000.00

950.00

Balance Carried to Balance Sheet

972.20

571.58

BRIEF DESCRIPTION OF THE COMPANY''S WORKING DURING THE YEAR/ STATE OF COMPANY''S AFFAIRS :

During the year under review, your Company achieved Net Sales of Rs.32123.52 Lacs and recorded a Gross Profit of Rs.3120.98 Lacs compared to previous year''s Net Sales of Rs. 32086.28 Lacs and Gross Profit of Rs. 3568.35 Lacs.

As reported in the last year, your Company has successfully launched Dhup Tab & Drop (Vit.D3), Inbalanse-Z (probiotic) and Evict-XF (Laxative).

During the current financial year, your Company plans to further strengthen Inbalanse range by launching Inbalanse Capsule & Inbalanse Ready solution.

Your Directors are hopeful of further growth in sales and better financial performance during the current year. DIVIDEND

Interim Dividend of Rs.5.50 per equity share of Rs.10/- each for the financial year ended 31st March, 2016 amounting to Rs.377.81 Lacs (inclusive of dividend distribution tax of Rs.63.90 Lacs) was paid during the year. Considering this, no final dividend is recommended by the Board.

TRANSFER TO RESERVES :

The Board proposes to transfer an amount of Rs.4000.00 Lacs to General Reserve.

CHANGE IN THE NATURE OF BUSINESS, IF ANY :

During the year under review, there has been no change in the nature of business of the Company.

MATERIAL CHANGES AND COMMITMENTS AFTER THE BALANCE SHEET DATE :

There was no material changes and commitments in the business operation of the Company, affecting the financial position of the Company which have occurred between the end of the financial year of the Company to which the financial statements relate and the date of the report.

DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY''S OPERATIONS IN FUTURE :

There was no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Company''s operations in future.

DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS :

1. The Company has appointed Internal Auditors to observe the Internal Controls, whether the work flow of organization is being done through the approved policies of the Company. In every quarter during the approval of Financial Statements, Internal Auditors present the Internal Audit Report and Management comments on the Internal Audit observations;

2. The Board of Directors of the Company have adopted various policies like Related Party Transaction Policy, Whistle Blower Policy and other procedures for ensuring the orderly and efficient conduct of its business. The Company''s system of internal control has been designed to provide a reasonable assurance with regard to maintaining of proper accounting controls, monitoring of operations, safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial information.

3. The Company is in process of installing ERP suite for a reliable, high end, comprehensive, disciplined and integrated business solution.

DEPOSITS :

The Company has outstanding deposits of Rs.437.75 Lacs as on 31st March, 2016 which was accepted from the shareholders of the Company in terms of section 73 of the Companies Act, 2013. There was no overdue deposit as on 31st March, 2016 except Rs.21.80 Lacs (including accrued interest of Rs.1.80 Lacs) which remained unclaimed.

STATUTORY AUDITORS :

M/s. G. Basu & Co., Kolkata, Chartered Accountants (Firm Registration No.301174E) had been appointed as Statutory Auditors of the Company by the members in their AGM held on 7th August, 2014 till the AGM of the Company to be held in 2017 (subject to ratification by members at every AGM). Accordingly, appointment of M/s. G. Basu & Co., Chartered Accountant, as Statutory Auditors of the Company for the financial year 2016-17 is placed for ratification by the shareholders.

M/s. G. Basu & Co., Kolkata, Chartered Accountants have signified their consent, in writing, for such appointment along with a certificate stating that their appointment, if made, shall be in accordance with Section 139 read with Section 141 of the Companies Act, 2013.

DETAILS OF SUBSIDIARY/JOINT VENTURES/ASSOCIATE COMPANIES :

The Company does not have any subsidiary/joint ventures/associate companies.

AUDITORS'' REPORT :

The Auditors'' Report to the shareholders on the accounts of the Company for the financial year ended 31st March 2016, does not contain any qualification, reservation or adverse remark or disclaimer.

SECRETARIAL AUDIT :

The provisions of Section 204 read with Section 134(3) of the Companies Act, 2013 mandates Secretarial Audit of the Company for the financial year 2015-2016 by a Company Secretary in Practice and accordingly the Board have appointed M/s. MKB & Associates, Practicing Company Secretary (C.P.No: 7596) as Secretarial Auditor to conduct Secretarial audit of the Company for the Financial year ended on 31st March, 2016.

Secretarial Audit Report issued by M/s. MKB & Associates, Practicing Company Secretary in form MR-3 is enclosed as "Annexure - 1" to this Annual Report.

There are no qualifications in Secretarial Audit Report.

COST AUDIT :

In accordance with the provisions of Section 148 of the Companies Act, 2013 and the Companies (Audit & Auditors) Rules, 2014, the Company is required to appoint a cost auditor to audit the cost records of the applicable products of the Company relating to the business of manufacturing Bulk Drugs and Formulations. Accordingly, M/s. S. Gupta & Co., Kolkata, Cost Accountants (Registration No.000020) were appointed as the Cost Auditors for auditing the Company''s cost accounts for the year ended 31st March, 2016.

As required under the Companies Act, 2013, the remuneration payable to the cost auditor is required to be placed before the Members in a general meeting for their ratification. Accordingly, a Resolution seeking Member''s ratification for the remuneration payable to M/s. S. Gupta & Co., Cost Auditors is included in the Notice convening the Annual General Meeting.

SHARE CAPITAL :

There is no change in the Share Capital of the Company during the year.

EXTRACT OF THE ANNUAL RETURN :

The extract of the Annual Return is prepared in Form MGT-9 as per the provisions of the Companies Act, 2013 and Rule 12 of the Companies (Management and Administration) Rules, 2014 and the same is enclosed as "Annexure - 2" to this Report.

THE CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO PURSUANT TO PROVISIONS OF SECTION 134(3)(m) OF THE COMPANIES ACT, 2013 (ACT) READ WITH THE COMPANIES (ACCOUNTS) RULES, 2014 :

Information with respect to conservation of energy, technology absorption, foreign exchange earnings and outgo pursuant to Section 134(3)(m) of the Act read with Companies (Accounts) Rules, 2014 is prepared and the same is enclosed as "Annexure - 3" to this Report.

CORPORATE SOCIAL RESPONSIBILITY (CSR) :

The Board of Directors of the Company have constituted Corporate Social Responsibility Committee consisting of following persons namely Mr. A. K. Kothari, designated as Chairman, Mr. K. P. Mundhra, Executive Director and Dr. K. Lahiri, Independent Director of the Company as members of the Committee.

The Board of Directors of the Company on the recommendation of CSR Committee has adopted a CSR Policy at its meeting held on 13th November, 2014 which inter-alia states the CSR activities to be taken by the Company. The Policy may be referred at the Company''s official website at http://www.albertdavidindia.com/investor-relation/si/csr.

The Company has contributed Rs.10.00 Lacs in discharging its corporate responsibility obligation during the year. In terms of section 135 of the Companies Act, 2013, an amount of Rs.34.80 Lacs was due. The balance amount of Rs.24.80 Lacs has been carried forward to the next year, as suitable project/programme could not be identified for carrying the activities as per CSR Policy of the Company.

Report on Corporate Social Responsibility as per Rule 8 of the Companies (Corporate Social Responsibility Policy) Rules 2014 is prepared and the same is enclosed as "Annexure - 4" to this Report.

DIRECTORS AND KEY MANAGERIAL PERSONNEL :

(a) Declaration by Independent Directors :

All the Independent Directors have submitted their declarations of independence pursuant to Section 149(7) of the Companies Act, 2013 stating that they meet the criteria of independence as laid down in section 149(6) of the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.

(b) Familiarization Programme undertaken for Independent Directors

The Independent Directors are familiarized with the Company, their roles, rights, responsibilities in the Company, nature of the industry in which the Company operates, business model of the Company, etc. pursuant to Regulation 25(7) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. On appointment, the Independent Director is issued a Letter of Appointment setting out in detail, the terms of appointment, duties, responsibilities and expected time commitments. Each newly appointed Independent Director is taken through a formal induction program on the Company''s operations, marketing, finance and other important aspects. The Company Secretary briefs the Director about their legal and regulatory responsibilities as a Director. The Director is also explained in detail the various compliances required from him as a Director under the various provisions of the Companies Act 2013, SEBI (LODR) Regulation, 2015, SEBI (Prohibition of Insider Trading) Regulations, 2011, the Code of Conduct of the Company and other relevant regulations. The details of familiarization program is available on the Company''s website under the weblink: http://www.albertdavidindia.com/investor-relation/si/ familiarization

(c) Non-Independent Director

In accordance with the provisions of Articles of Association of the Company, Mrs. Prabhawati Devi Kothari, Director of the Company, is liable to retire by rotation and being eligible, offer herself for re-appointment. The Board recommends her appointment with a view to avail her valuable advices and wise counsel.

A brief profile of the above Director seeking appointment/re-appointment required under Regulation 36(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 is given in the Notice of AGM forming part of the Annual Report.

None of the Directors of the Company are disqualified for being appointed as Directors, as specified in section 164(2) of the Companies Act, 2013 and rule 14(1) of the Companies (Appointment and Qualification of Directors) Rules 2014.

(d) Change in Directorship during the year

There was no change in Directorship during the year. Mr. K P Mundhra, Wholetime Director, who was re-appointed by the Board as the Executive Director in its meeting held on 28th March, 2016 for a period of one year with effect from 1st April 2016, has resigned with effect from 1st July, 2016. The Board put on record their appreciation for the valuable services rendered by Mr. K P Mundhra during his tenure.

(e) Key Managerial Personnel

Mr. A. K. Kothari, Chairman & Managing Director, Mr. K. P. Mundhra, Executive Director, Mr. S. C. Shah, Vice President(Finance) & CFO and Dr. Indrajit Dhar, Associate Vice President (Accounts & Taxation)-cum-Company Secretary were re-designated as Whole-time Key Managerial Personnel of the Company as per section 203(2) of the Companies Act, 2013.

ANNUAL EVALUATION OF BOARD''S PERFORMANCE :

Pursuant to the provisions of Section 178 of the Companies Act 2013 and the SEBI Listing Regulations, evaluation of all Board members is done on an annual basis. The evaluation is done by the Board, Nomination and Remuneration Committee and Independent Directors with specific focus on the performance and effective functioning of the Board and Individual Directors. A structured questionnaire was prepared after taking into consideration inputs received from the Directors, covering various aspects of the Board''s functioning such as adequacy of the composition of the Board and its Committees, Board culture, execution and performance of specific duties, obligations and governance.

a) Criteria for evaluation of Board of Directors as a whole

i. The frequency of meetings;

ii. The length of meetings;

iii. The administration of meeting;

iv. The number of committees and their roles;

v. The flow of information to board members and between board members;

vi. The quality and quantity of information; and

vii. The Disclosure of Information to the stakeholders.

b) Criteria for evaluation of the Individual Directors

i. Ability to contribute and monitor corporate governance practices;

ii. Ability to contribute by introducing best practices to address top management issues;

iii. Participation in long term strategic planning;

iv. Commitment to the fulfillment of director obligations and fiduciary responsibilities;

v. Guiding strategy;

vi. Monitoring management performance and development;

vii. Statutory compliance & Corporate governance;

viii. Attendance and contribution at Board/Committee meetings;

ix. Time spent by each of the member; and

x. Core competencies.

The Directors expressed their satisfaction over the evaluation process and results thereof.

NUMBER OF MEETINGS OF THE BOARD OF DIRECTORS :

During the financial year ended 31st March, 2016 seven Board Meetings were held on 28th May, 2015, 12th August, 2015, 14th November, 2015, 27th January, 2016, 10th February, 2016, 14th March, 2016 and 28th March, 2016. The maximum time gap between any two meetings was less than four months as stipulated under SEBI (LODR) Regulation, 2015. Details of board meetings held during the financial year have been furnished in the Corporate Governance Report forming part of this Annual Report.

MEETINGS OF INDEPENDENT DIRECTORS

During the year under review, a meeting of Independent Directors was held on 10th February, 2016 wherein the performance of the non-independent directors and the Board as a whole was reviewed. The Independent Directors at their meeting also assessed the quality, quantity and timeliness of flow of information between the Company management and the Board of Directors of the Company.

COMMITTEES OF THE BOARD :

The Company has constituted/re-constituted various Board level committees in accordance with the requirements of Companies Act 2013. Details of all the above Committees along with composition and meetings held during the year under review are provided in the Report on Corporate Governance forming part of this report.

AUDIT COMMITTEE :

The composition and terms of reference of the Audit Committee has been furnished in the Corporate Governance Report forming a part of this Annual Report. There has been no instances where the Board has not accepted the recommendations of the Audit Committee.

NOMINATION AND REMUNERATION COMMITTEE :

The composition and terms of reference of the Nomination and Remuneration Committee has been furnished in the Corporate Governance Report forming part of this Annual Report.

POLICY ON DIRECTORS'' APPOINTMENT AND REMUNERATION :

A Nomination and Remuneration Policy has been formulated pursuant to the provisions of Section 178 and other applicable provisions of the Companies Act, 2013 and Rules thereto stating therein the Company''s policy on Directors'' appointment and remuneration by the Nomination and Remuneration Committee which was approved by the Board of Directors at its meeting held on 27th May, 2014. The said Policy is appended as "Annexure - 5" to this Report.

The said policy may also be referred to, at the Company''s official website at the weblink, http://www.albertdavidindia.com/investor-relation/si/nr-policy

WHISTLE BLOWER MECHANISM/VIGIL MECHANISM :

The Company has established an effective Whistle Blower Policy pursuant to Companies Act, 2013. The said policy may be referred to, at the Company''s official website at the weblink, http://www.albertdavidindia.com/investor-relation/si/ whistle-blower-policy

The Whistle Blower Policy aims for conducting the affairs in a fair and transparent manner by adopting highest standards of professionalism, honesty, integrity and ethical behavior. All permanent employees of the Company are covered under the Whistle Blower Policy.

A mechanism has been established for employees to report concerns about unethical behavior, actual or suspected fraud or violation of Code of Conduct and Ethics. It also provides for adequate safeguards against the victimization of employees who avail of the mechanism and allows direct access to the Chairman of the audit committee in exceptional cases.

DISCLOSURE AS REQUIRED UNDER SECTION 22 OF SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013 :

The Company as an organization is committed to provide a healthy environment to all employees and thus does not tolerate any discrimination and/or harassment in any form. The Company has in place a Prevention of Sexual Harassment Policy in line with the requirement of the Sexual Harassment of Women at work place (Prevention, Prohibition and Redressal) Act, 2013. The Company has set up Internal Complaint Committee which is chaired by Female employee of the Company. No complaints were received during the financial year 2015-2016.

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS :

Details of Loans, guarantees and investments covered under Section 186 of the Act form part of the Note No.28.14 to the Financial Statements provided in this Annual Report.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES :

A Related Party Policy has been devised by the Board of Directors at its meeting held on 9th February, 2015 for determining the materiality of transactions with related parties and dealings with them. The said policy may be referred to, at the Company''s official website at the weblink, http://www.albertdavidindia.com/investor-relation/si/rp-transaction

The Audit Committee reviews all related party transactions quarterly.

There are no contracts or arrangements entered into by the Company during the year with Related Parties referred to in Section 188(1) of the Companies Act, 2013. There are no materially significant related party transactions made by the Company with promoters, directors, key managerial personnel or other designated persons which may have a potential conflict with the interest of the Company at large.

Directors draw attention of the members to Note No.28.2 to the financial statement which set out related party disclosures.

STATEMENT OF PARTICULARS OF APPOINTMENT AND REMUNERATION OF MANAGERIAL PERSONNEL :

Details of the ratio of the remuneration of each director to the median employee''s remuneration and other details as required pursuant to Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is enclosed as "Annexure - 6" to this Annual Report.

Details of the every employee of the Company as required pursuant to 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is enclosed as "Annexure - 7" to this Annual Report.

MANAGEMENT DISCUSSION ANALYSIS AND CORPORATE GOVERNANCE :

A separate report on Corporate Governance and Management''s Discussion and Analysis is annexed as part of the Annual Report along with the Auditor ''s Certificate in compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.

RISK & MITIGATING STEPS :

The Company has identified various risks faced by the Company from different areas. Appropriate structures are present so that risks are inherently monitored and controlled inter alia through strict quality assurance measures.

The Company has adequate internal control system and procedures to combat risks. The risk management procedure is reviewed by the Audit Committee and Board of Directors on a quarterly basis at the time of review of quarterly financial results of the Company.

DIRECTORS'' RESPONSIBILITY STATEMENT :

Pursuant to clause (c) of sub-section (3) of Section 134 and Section 134(5) of the Companies Act, 2013, the Board of Directors of the Company hereby state and confirm that :

i) in the preparation of the annual accounts for the year ended March 31, 2016, the applicable accounting standards had been followed along with proper explanation relating to material departures, if any ;

ii) the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on 31st March, 2016 and of the profit of the Company for that period ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended 31st March, 2016 in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities ;

iv) the Directors had prepared the annual accounts on a ''going concern basis'';

v) the Directors had laid down internal financial controls to be followed by the Company and that such internal financial controls with reference to the financial statements are adequate and were operating effectively ; and

vi) the Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

TRANSFER TO INVESTOR EDUCATION & PROTECTION FUND :

The Company has transferred unclaimed dividend amounts till the year ended 31st March, 2008 to the Investor Education & Protection Fund established by the Central Government in compliance to the provisions of the Companies Act.

Pursuant to the provisions of IEPF (Uploading of Information regarding Unpaid and Unclaimed Amounts lying with companies) Rules, 2012, the Company has uploaded the details of Unclaimed Dividend lying with the Company on the its website http://www.albertdavidindia.com/investor-relation/si/iep-fund, as also on the website of Ministry of Corporate Affairs.

LISTING WITH STOCK EXCHANGES :

Your Company is listed with BSE Limited and the Company has paid the listing fees.

ACKNOWLEDGMENT :

The Board gratefully acknowledges the support given by medical profession, trade, shareholders, Company''s bankers and stockiest, Central and State Government Authorities, Stock Exchange, CDSL, NSDL and all other Business Associates for the growth of the organization. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

For and on behalf of the

Board of Directors

Kolkata A. K. Kothari

Dated : 30th May, 2016 Chairman & Managing Director

DIN : 00051900


Mar 31, 2015

TO THE SHAREHOLDERS

Ladies & Gentlemen,

The Directors have pleasure in presenting their 76th Annual Report on the business and operations of the Company and the accounts for the financial year ended 31st March, 2015

FINANCIAL HIGHLIGHTS/PERFORMANCE OF THE COMPANY :

(Rs. in Lacs) 2014-2015 2013-2014

Net Sales 32086.28 28984.81

Earning before Interest, Depreciation, Tax & Ammortisation [EBIDTA] 3658.38 3250.31

Other Income 179.59 60.17

Finance Costs 269.62 358.69

Gross Profit (EBDTA) 3568.35 2951.79

Depreciation and Amortization 1541.46 1105.73

Profit Before Tax [PBT] 2026.89 1846.06

Provision for Taxation 656.86 588.74

Net Profit after Tax [PAT] 1370.03 1257.32

Balance of Profit brought forward from 529.34 505.88 previous year

Surplus available for appropriation 1899.37 1763.20

Appropriations :

Proposed Dividend 313.89 285.36

Tax on Dividend 63.90 48.50

Transfer to General Reserve 950.00 900.00

Balance Carried to Balance Sheet 571.58 529.34

BRIEF DESCRIPTION OF THE COMPANY''S WORKING DURING THE YEAR/

STATE OF COMPANY''S AFFAIRS :

During the year under review, your Company achieved Net Sales of Rs.32086.28 Lacs and recorded a Gross Profit of Rs.3568.35 Lacs compared to previous year''s Net Sales of Rs.28984.81 Lacs and Gross Profit of Rs.2951.79 Lacs registering a growth of 10.70 % and 20.89 % respectively over the last year.

As reported in the last year, your Company has successfully launched Alamin Liquid and Alamin RLD (L-Arginine Sachet). During the current financial year, your Company plans to further strengthen Evict range by launching EVICT-XF.

The success of Derek & Breaze range has opened up the possibilities to venture in pre-probiotic and respiratory markets. Also we shall further strengthen our Gynae portfolio.

Your Directors are hopeful of further growth in sales and better financial performance during the current year.

DIVIDEND

The Board of Directors of your Company is pleased to recommend payment of dividend of Rs.5.50 per equity share of Rs.10/- each for the financial year ended 31st March, 2015 amounting to Rs.377.79 Lacs (inclusive of dividend distribution tax of Rs.63.90 Lacs).

TRANSFER TO RESERVES :

The Board proposes to transfer an amount of Rs.950.00 Lacs to General Reserve.

CHANGE IN THE NATURE OF BUSINESS, IF ANY :

During the year under review, there has been no change in the nature of business of the Company.

MATERIAL CHANGES AND COMMITMENTS AFTER THE BALANCE SHEET DATE :

There was no material changes and commitments in the business operation of the Company, affecting the financial position of the Company which have occurred between the end of the financial year of the Company to which the financial statements relate and the date of the report.

DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANY''S OPERATIONS IN FUTURE :

There was no significant and material orders passed by the Regulators or Courts or Tribunals impacting the going concern status and Company''s operations in future.

DETAILS IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS :

1. The Company has appointed Internal Auditors to observe the Internal Controls, whether the work flow of organization is being done through the approved policies of the Company. In every quarter during the approval of Financial Statements, Internal Auditors present the Internal Audit Report and Management comments on the Internal Audit observations;

2. The Board of Directors of the Company have adopted various policies like Related Party Transaction Policy, Whistle Blower Policy and other procedures for ensuring the orderly and efficient conduct of its business. The Company''s system of internal control has been designed to provide a reasonable assurance with regard to maintaining of proper accounting controls, monitoring of operations, safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial information.

3. The Company is in process of installing ERP suite for a reliable, high end, comprehensive, disciplined and integrated business solution.

DETAILS OF SUBSIDIARY/JOINT VENTURES/ASSOCIATE COMPANIES :

The Company does not have any subsidiary/joint ventures/associate companies.

DEPOSITS :

During the year, the Company has not accepted any deposit in terms of Section 73 of the Companies Act, 2013. There was no overdue deposit as on 31st March, 2015 except Rs.21.80 Lacs (including accrued interest of Rs.1.80 Lacs) which remained unclaimed.

STATUTORY AUDITORS :

M/s. G. Basu & Co., Kolkata, Chartered Accountants (Registration No.301174E) had been appointed as Statutory Auditors of the Company by the members in their AGM held on 7th August, 2014 till the AGM of the Company to be held in 2017 (subject to ratification by members at every AGM). Accordingly, appointment of M/s. G. Basu & Co., Chartered Accountant, as Statutory Auditors of the Company for the financial year 2015-16 is placed for ratification by the shareholders.

M/s. G. Basu & Co., Kolkata, Chartered Accountants have signified their consent, in writing, for such appointment along with a certificate stating that their appointment, if made, shall be in accordance with Section 139 read with Section 141 of the Companies Act, 2013.

The Auditors'' Report to the shareholders on the accounts of the Company for the financial year ended 31st March, 2015 does not contain any qualification, reservation or adverse remark or disclaimer.

SECRETARIAL AUDIT :

The provisions of Section 204 read with Section 134(3) of the Companies Act, 2013 mandates Secretarial Audit of the Company for the financial year 2014-2015 by a Company Secretary in Practice and accordingly the Board have appointed M/s. Dipti Kumar Gupta, Practicing Company Secretary (C.P.No: 9506) as Secretarial Auditor to conduct Secretarial audit of the Company for the Financial year ended on 31st March, 2015.

Secretarial Audit Report issued by M/s. Dipti Kumar Gupta, Practicing Company Secretary in form MR-3 is enclosed as "Annexure - 1" to this Annual Report.

There are no qualifications in Secretarial Audit Report

COST AUDIT :

In accordance with the provisions of Section 148 of the Companies Act, 2013 and the Companies (Audit & Auditors) Rules, 2014, the Company is required to appoint a cost auditor to audit the cost records of the applicable products of the Company relating to the business of manufacturing Bulk Drugs and Formulations. Accordingly, M/s. S. Gupta & Co., Kolkata, Cost Accountants (Registration No.000020) were appointed as the Cost Auditors for auditing the Company''s cost accounts for the year ended 31st March, 2015.

SHARE CAPITAL :

There is no change in the Share Capital of the Company during the year.

EXTRACT OF THE ANNUAL RETURN :

The extract of the Annual Return is prepared in Form MGT-9 as per the provisions of the Companies Act, 2013 and Rule 12 of the Companies (Management and Administration) Rules, 2014 and the same is enclosed as "Annexure-2" to this Report.

THE CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO PURSUANT TO PROVISIONS OF SECTION 134(3)(m) OF THE COMPANIES ACT, 2013 (ACT) READ WITH THE COMPANIES (ACCOUNTS) RULES, 2014 :

Information with respect to conservation of energy, technology absorption, foreign exchange earnings and outgo pursuant to Section 134(3)(m) of the Act read with Companies (Accounts) Rules, 2014 is prepared and the same is enclosed as "Annexure - 3" to this Report.

CORPORATE SOCIAL RESPONSIBILITY (CSR) :

The Board of Directors of the Company have constituted Corporate Social Responsibility Committee consisting of following persons namely Mr. A. K. Kothari, designated as Chairman, Mr. K. P. Mundhra, Executive Director and Dr. K. Lahiri, Independent Director of the Company as members of the Committee.

The Board of Directors of the Company on the recommendation of CSR Committee has adopted a CSR Policy at its meeting held on 13th November, 2014 which inter-alia states the CSR activities to be taken by the Company. The Policy may be referred at the Company''s official website at http://www.albertdavidindia.com/investor-relation/si/csr

The Company has contributed Rs.29.00 Lacs in discharging its corporate responsibility obligation during the year in due adherence of stipulation contained under section 135 of the Companies Act, 2013.

Report on Corporate Social Responsibility as per Rule 8 of the Companies (Corporate Social Responsibility Policy) Rules 2014 is prepared and the same is enclosed as "Annexure-4" to this Report.

DIRECTORS :

Changes in Directors and Key Managerial Personnel

(a) Appointment of Independent Directors

Mr. Arindam Sarkar has been inducted on the Board of the Company with effect from 7th August, 2014 as an Additional cum Independent Director, subject to regularisation/approval of the members in the ensuing Annual General Meeting for a term of 5 consecutive years with effect from his date of appointment.

The Company has received notice from a shareholder pursuant to Section 160 of the Companies Act, 2013 proposing appointment of Mr. Arindam Sarkar as Director of the Company. Appropriate resolution seeking his appointment is appearing in the Notice convening the Annual General Meeting of the Company.

(b) Declaration by Independent Directors :

All the Independent Directors have submitted their declarations of independence pursuant to Section 149(7) of the Companies Act, 2013 stating that they meet the criteria of independence as laid down in section 149(6) of the Companies Act, 2013 and Clause 49 of the Listing Agreement.

(c) Familiarization Program undertaken for Independent Directors

The Independent Directors are familiarised with the Company, their roles, rights, responsibilities in the Company, nature of the industry in which the Company operates, business model of the Company, etc. On appointment, the Independent Director is issued a Letter of Appointment setting out in detail, the terms of appointment, duties, responsibilities and expected time commitments. Each newly appointed Independent Director is taken through a formal induction program on the Company''s operations, marketing, finance and other important aspects. The Company Secretary briefs the Director about their legal and regulatory responsibilities as a Director. The familiarization program is available on the Company''s website under the weblink : http:Wwww.albertdavidindia.com/investor-relation/si/familiarisation

(d) Non-Independent Director

In accordance with the provisions of Articles of Association of the Company, Mrs. Prabhawati Devi Kothari, Director of the Company, is liable to retire by rotation and being eligible, offer herself for re-appointment. The Board recommends her appointment with a view to avail her valuable advices and wise counsel.

A brief profile of the above Directors seeking appointment/re-appointment required under Clause 49 of the Listing Agreement, is given in the Notice of AGM.

(e) Change in Directorship during the year

Mr. D. D. Binani resigned from the Board and his resignation was accepted with effect from 13th November, 2014 by the Board in their meeting held on 13th November, 2014. The Board places on record their deep sense of appreciation for his valuable advice and guidance during his association with the Company.

(f) Key Managerial Personnel

Mr. A. K. Kothari, Chairman & Managing Director, Mr. K. P. Mundhra, Executive Director, Mr. S. C. Shah, Vice President(Finance) & CFO and Dr. Indrajit Dhar, Associate Vice President (Accounts & Taxation)-cum-Company Secretary were re-designated as Whole-time Key Managerial Personnel of the Company as per section 203(2) of the Companies Act, 2013.

ANNUAL EVALUATION OF BOARD''S PERFORMANCE :

Evaluation of all Board members is done on an annual basis. The evaluation is done by the Board, Nomination and Remuneration Committee and Independent Directors with specific focus on the performance and effective functioning of the Board and Individual Directors. A structured questionnaire was prepared after taking into consideration inputs received from the Directors, covering various aspects of the Board''s functioning such as adequacy of the composition of the Board and its Committees, Board culture, execution and performance of specific duties, obligations and governance.

a) Criteria for evaluation of Board of Directors as a whole

i. The frequency of meetings;

ii. The length of meetings;

iii. The administration of meeting;

iv. The number of committees and their roles;

v. The flow of information to board members and between board members;

vi. The quality and quantity of information; and

vii. The Disclosure of Information to the stakeholders.

b) Criteria for evaluation of the Individual Directors

i. Ability to contribute and monitor corporate governance practices;

ii. Ability to contribute by introducing best practices to address top management issues;

iii. Participation in long term strategic planning;

iv. Commitment to the fulfillment of director obligations and fiduciary responsibilities;

v. Guiding strategy;

vi. Monitoring management performance and development;

vii. Statutory compliance & Corporate governance;

viii. Attendance and contribution at Board/Committee meetings;

ix. Time spent by each of the member; and

x. Core competencies.

The Directors expressed their satisfaction over the evaluation process and results thereof.

NUMBER OF MEETINGS OF THE BOARD OF DIRECTORS :

During the financial year ended 31st March, 2015 four Board Meetings were held. Details of board meetings held during the financial year have been furnished in the Corporate Governance Report forming part of this Annual Report.

MEETINGS OF INDEPENDENT DIRECTORS

During the year under review, a meeting of Independent Directors was held on 9th February, 2015 wherein the performance of the non-independent directors and the Board as a whole was reviewed. The Independent Directors at their meeting also assessed the quality, quantity and timeliness of flow of information between the Company management and the Board of Directors of the Company.

AUDIT COMMITTEE :

The composition and terms of reference of the Audit Committee has been furnished in the Corporate Governance Report forming a part of this Annual Report. There has been no instances where the Board has not accepted the recommendations of the Audit Committee.

NOMINATION AND REMUNERATION COMMITTEE :

The composition and terms of reference of the Nomination and Remuneration Committee has been furnished in the Corporate Governance Report forming part of this Annual Report.

POLICY ON DIRECTORS'' APPOINTMENT AND REMUNERATION :

A Nomination and Remuneration Policy has been formulated pursuant to the provisions of Section 178 and other applicable provisions of the Companies Act, 2013 and Rules thereto stating therein the Company'' policy on Directors'' appointment and remuneration by the Nomination and Remuneration Committee which was approved by the Board of Directors at its meeting held on 27th May, 2014. The said Policy is appended as "Annexure-5" to this Report.

The said policy may also be referred to, at the Company''s official website at the weblink, http://www.albertdavidindia.com/ investor-relation/si/nr-policy

WHISTLE BLOWER MECHANISM/VIGIL MECHANISM :

The Company has a Whistle Blower Policy in place pursuant to Companies Act, 2013 and Clause 49 of the Listing Agreement. The said policy may be referred to, at the Company''s official website at the weblink, http://www.albertdavidindia.com/ investor-relation/si/whistle-blower-policy

The Whistle Blower Policy aims for conducting the affairs in a fair and transparent manner by adopting highest standards of professionalism, honesty, integrity and ethical behavior. All permanent employees of the Company are covered under the Whistle Blower Policy.

A mechanism has been established for employees to report concerns about unethical behavior, actual or suspected fraud or violation of Code of Conduct and Ethics. It also provides for adequate safeguards against the victimization of employees who avail of the mechanism and allows direct access to the Chairman of the audit committee in exceptional cases.

DISCLOSURE AS REQUIRED UNDER SECTION 22 OF SEXUAL HARASSMENT OF WOMEN AT WORK PLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013 :

The Company as an organization is committed to provide a healthy environment to all employees and thus does not tolerate any discrimination and/or harassment in any form. The Company has in place a Prevention of Sexual Harassment Policy in line with the requirement of the Sexual Harassment of Women at work place (Prevention, Prohibition and Redressal) Act, 2013. The Company has set up Internal Complaint Committee which is chaired by Female employee of the Company. No complaints were received during the financial year 2014-2015.

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS :

During the year, the Company has given loans of Rs.100.00 lacs and Rs.300.00 lacs to M/s. EMC Limited and M/s. Gillanders Arbuthnot & Co. Ltd. for short term period at an interest rate of 16% and 13.5% per annum respectively. Grant of the said loans are within the power of the Board of Directors. The loans have been repaid during the year.

No investment was made or guarantee was given by the Company during the year under review.

PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES :

A Related Party Policy has been devised by the Board of Directors at its meeting held on 9th February, 2015 for determining the materiality of transactions with related parties and dealings with them. The said policy may be referred to, at the Company''s official website at the weblink, http://www.albertdavidindia.com/investor-relation/si/rp-transaction. The Audit Committee reviews all related party transactions quarterly.

There are no contracts or arrangements entered into by the Company during the year with Related Parties referred to in Section 188(1) of the Companies Act, 2013.

STATEMENT OF PARTICULARS OF APPOINTMENT AND REMUNERATION OF MANAGERIAL PERSONNEL :

Details of the ratio of the remuneration of each director to the median employee''s remuneration and other details as required pursuant to Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is enclosed as "Annexure-6" to this Annual Report.

Details of the every employee of the Company as required pursuant to 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is enclosed as "Annexure-7" to this Annual Report.

CORPORATE GOVERNANCE :

A separate report on Corporate Governance and Management''s Discussion and Analysis is annexed as part of the Annual Report along with the Auditor''s Certificate on compliance with the condition of Corporate Governance under Clause 49 of the Listing Agreement.

RISK & MITIGATING STEPS :

The Company has identified various risks faced by the Company from different areas. Appropriate structures are present so that risks are inherently monitored and controlled inter alia through strict quality assurance measures.

The Company has adequate internal control system and procedures to combat risks. The risk management procedure is reviewed by the Audit Committee and Board of Directors on a quarterly basis at the time of review of quarterly financial results of the Company.

Pursuant to clause (c) of sub-section (3) of Section 134 and Section 134(5) of the Companies Act, 2013, the Board of Directors of the Company hereby state and confirm that :

i) in the preparation of the annual accounts for the year ended March 31, 2015, the applicable accounting standards

had been followed along with proper explanation relating to material departures, if any ;

ii) the Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on 31st March, 2015 and of the profit of the Company for that period ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended 31st March, 2015 in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities ;

iv) the Directors had prepared the annual accounts on a ''going concern basis'';

v) the Directors had laid down internal financial controls to be followed by the Company and that such internal financial

controls with reference to the financial statements are adequate and were operating effectively ; and

vi) the Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

TRANSFER TO INVESTOR EDUCATION & PROTECTION FUND :

The Company has transferred unclaimed dividend amounts till the year ended 31st March, 2007 to the Investor Education & Protection Fund established by the Central Government in compliance to the provisions of the Companies Act.

Pursuant to the provisions of IEPF (Uploading of Information regarding Unpaid and Unclaimed Amounts lying with companies) Rules, 2012, the Company has uploaded the details of Unclaimed Dividend lying with the Company on the its website http:www.albertdavidindia.com, investor-relation/si/iep-fund as also on the website of Ministry of Corporate Affairs.

LISTING WITH STOCK EXCHANGES :

Your Company is listed with BSE Limited and the Company has paid the listing fees.

ACKNOWLEDGMENT :

The Board gratefully acknowledges the support given by medical profession, trade, shareholders, Company''s bankers and stockists, Central and State Government Authorities, Stock Exchange, CDSL, NSDL and all other Business Associates for the growth of the organization. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

For and on behalf of the Board of Directors

Kolkata A. K. Kothari Dated : 28th May, 2015 Chairman & Managing Director DIN : 00051900


Mar 31, 2014

The Directors have pleasure to present the 75th Annual Report on the performance of your Company together with the Audited Statement of Accounts for the year ended 31st March, 2014

Financial results

(Rs. in Lacs) 2013-2014 2012-2013

Net Sales 29148.25 26417.42

Earning before Interest, depreciation, Tax & amortisation [EBIdTa] 3139.37 2560.82

Other Income 171.11 175.43

Finance Costs 358.69 324.26

Gross Profit (EBdTa) 2951.79 2411.99

Depreciation and Amortisation 1105.73 1073.47

Profit Before Tax [PBT] 1846.06 1338.52

Provision for Taxation 588.74 482.65

Net Profit after Tax [PaT] 1257.32 855.87

Balance of Profit brought forward from previous year 505.88 500.48

Surplus available for appropriation 1763.20 1356.35

appropriations :

Proposed Dividend 285.36 256.82

Tax on Dividend 48.50 43.65

Transfer to General Reserve 900.00 550.00

Balance Carried to Balance Sheet 529.34 505.88

WorKiNG resULts :

During the year under review, your Company achieved net Sales of Rs.29148.25 Lacs and recorded a Gross Profit of Rs.2951.79 Lacs compared to previous year''s net Sales of Rs.26417.42 Lacs and Gross Profit of Rs.2411.99 Lacs registering a growth of 10.34% and 22.38% respectively over the last year.

As reported in the last year, your company has successfully launched Rabeprazole and its combination (Anti-Peptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range).

During the current financial year, your company plans to further strengthen Alamin range of products by launching Alamin Liquid, Alamin Drops and other variants of L Arginine Sachets.

Also we have plans to venture into Pre-probiotic and Infertility market.

Your Directors are hopeful of further growth in sales and better financial performance during the current year.

Dividend :

The Board of Directors of your Company is pleased to recommend payment of dividend of Rs.5/- per equity share of Rs.10/- each for the financial year ended 31st March, 2014 amounting to Rs.333.86 Lacs (inclusive of dividend distribution tax of Rs.48.50 Lacs).



Fixed Deposits :

The Company has outstanding Public Deposits amounting to Rs.807.25 Lacs as on 31st March, 2014. There was no overdue deposit on 31st March, 2014 except Rs.21.80 Lacs (including accrued interest of Rs.1.80 Lacs) which remain unclaimed.

Board of Directors :

Mrs. Prabhawati Devi Kothari, Dr. Amal Kumar Bhattacharya and Dr. Karunamay Lahiri joined the Board of the company with effect from 31st March, 2014 as Additional Directors. They will hold such office only upto the date of the ensuing Annual General Meeting of the company. The Company has received requisite notices in writing from members proposing Mrs. Prabhawati Devi Kothari for appointment as Director liable to retire by rotation and for appointment of Dr. Amal Kumar Bhattacharya and Dr. Karunamay Lahiri as Independent Directors of the Company for a term of 5 consecutive years with effect from the date of ensuing Annual General Meeting tell 31st March 2019, subject to the approval of the members.

In order to align the term of existing Independent Directors with the provisions of the Companies Act, 2013, the Board of Directors in their meeting held on 27th May, 2014 has proposed the appointment of Mr. Hemal Kampani and Mr. Rajiv Singhi as Independent Directors of the Company for a term of 5 consecutive years with effect from the date of ensuing Annual General Meeting till 31st March 2019, subject to the approval of the members.

The Company has received declarations from all the Independent Directors of the Company confirming that they meet with the criteria of independence as prescribed both under sub-section (6) of Section 149 of the Companies Act, 2013 and under Clause 49 of the Listing Agreement with the Stock Exchange.

In accordance with the provisions of Articles of Association of the Company, Mr. D D Binani, Director of the company, is liable to retire by rotation and being eligible, offer himself for re-appointment.

The Board recommends the appointment of above directors with a view to avail their valuable advices and wise counsel. A brief profile of the above Directors seeking appointment/re-appointment required under Clause 49 of the Listing Agreement, is given in the Notice of AGM.

Shri P L Agarwal and Shri A V Iyengar resigned from the Board and their resignations were accepted with effect from 31st March, 2014 by the Board in their meeting held on 31st March, 2014. The Board places on record their high sense of appreciation for their valuable advices and guidances given during their association with the company.

directors RESPONSIBILITY Statement :

Pursuant to sub-section (2AA) of Section 217 of the Companies Act, 1956, the Board of Directors of the Company hereby state and confirm that:

i) in the preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any;

ii) the Directors had selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on 31st March, 2014 and of the profit of the Company for the year ended as on date ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended 31st March, 2014 in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities ; and

iv) the Directors had prepared the annual accounts on a ''going concern basis''.

particulars of employees :

Particular of Employees as required in term of provision of Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended are set out in Annexure-I to the Directors'' Report.

conservation of energy, technology Absorption, Foreign exchange earning AND outgo :

Particulars required under Section 217(1)(e) of the Companies Act, 1956 read with the Companies (Disclosure of Particulars in the Report of Board of Directors) Rules, 1988 regarding Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo, are given in Annexure-II forming part of this Report.

corporate Governance :

Your Company believes Corporate Governance is at the core of stake holders'' satisfaction. The Annual Report contains a separate section on Corporate Governance which forms part of this Report.

The Compliance Report on Corporate Governance and a certificate from M/s. G. Basu & Co., Kolkata, Chartered Accountants, Statutory Auditors of the Company regarding compliance of the condition of corporate governance, as stipulated under clause 49 of the listing agreement with the stock exchange, is forming part of this Report.

Management''s Discussion and Analysis has been separately annexed with this report.

As a measure of good corporate governance, M/s. Ashok Kumar Daga, a Practicing Company Secretary conducts Annual Secretarial Compliance Audit of the company.

research & Development Activity :

Unlike other manufactory, there is fast product obsoletion in Pharma industry. Therefore, the product portfolio is a dynamic one and requires continuous strengthening with new developments. Ever changing regulatory requirements calls for back up of database with Quality Assurance. Companies are making more and more investments in R&D not only to support the changing regulatory requirements but also to remain afloat with continuous flow of products developed at R&D.

The Company''s Research & Development Unit at Kolkata has been recognised by Department of Scientific and Industrial Research (DSIR), Government of India. The Research & Development Section of the company has been engaged in developing innovative process developments, analytical methods and process validations. It has also been working on development of new products.

credit profile :

CRISIL Limited has affirmed [CRISIL A2 ] (pronounced as CRISIL A Two Plus) in respect of Short Term rating. This rating indicates strong degree of safety regarding timely payment of financial obligations. Such instruments carry low credit risk.

CRISIL Limited has reaffirmed [CRISIL A-] (pronounced as CRISIL A Minus/Stable) in respect of Long Term rating. This rating indicates adequate degree of safety regarding timely servicing of financial obligations. Such instruments carry low credit risk.

Listing of shares :

The equity shares of your Company are at present listed on BSE Ltd. Your Directors confirm that the Annual Listing Fee for 2013-2014 has been paid to the said Stock Exchange.

Auditors :

Statutory auditors & Report

M/s. G. Basu & Co., Kolkata, Chartered Accountants, Statutory Auditors of the company, will retire at the conclusion of the ensuing Annual General Meeting and being eligible, offer themselves for re-appointment as Statutory Auditors for the financial year 2014-2015.

M/s. G. Basu & Co., Kolkata, Chartered Accountants have signified their consent, in writing, for such appointment along with a certificate stating that their appointment, if made, shall be in accordance with Section 139 read with Section 141 of the Companies Act, 2013.

Based on the recommendation of the Audit Committee, the Board of Director of the company proposes the re-appointment of M/s. G. Basu & Co., Kolkata, Chartered Accountants as Statutory Auditors of the Company for a term of three consecutive years from the date of ensuing Annual General Meeting till conclusion of the Annual General Meeting to be held in the year 2017, subject to the approval of the members.

The Auditors'' Report to the shareholders on the accounts of the Company for the financial year ended 31st March, 2014 does not contain any qualification.

Cost auditors and Cost audit Report

The Central Government has approved the appointment of M/s. S. Gupta & Co., Kolkata, Cost Accountant, Registration No.000020 as Cost Auditor for conducting cost audit relating to Bulk Drugs, Formulations and Disposable Syringes & Needles for the financial year 2013-2014.

The Board of Directors in their meeting held on 27th May, 2014 have appointed M/s. S Gupta & Co., Cost Accountants as the Cost Auditor for the financial year 2014-2015.

Acknowledgment :

The Board gratefully acknowledges the support given by medical profession, trade, shareholders, company''s bankers and stockiest. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

For and on behalf of the Board of Directors

Kolkata A K Kothari

Dated : 27th May, 2014 Chairman & Managing Director


Mar 31, 2013

TO THE SHAREHOLDERS

Ladies & Gentlemen,

The Directors have pleasure to present the 74th Annual Report on the performance of your Company together with the Audited Statement of Accounts for the year ended 31st March, 2013

FINANCIAL RESULTS

(Rs. in Lacs)

2012-2013 2011-2012

Net Sales 26417.42 22974.39

Earning before Interest, Depreciation, Tax & Ammortisation [EBIDTA] 2668.00 2349.16

Other Income 68.25 96.12

Finance Charges 324.26 343.86

Depreciation 1073.47 977.57

Profit Before Tax 1338.52 1123.85

Provision for Taxation 482.65 361.01

Net Profit after Tax 855.87 762.84

Balance of Profit brought forward from previous year 500.48 536.12

Surplus available for appropriation 1356.35 1298.96

Appropriations :

Proposed Dividend 256.82 256.82

Dividend Distribution Tax 43.65 41.66

Transfer to General Reserve 550.00 500.00

Balance Carried to Balance Sheet 505.88 500.48

WORKING RESULTS

During the year under review, your Company achieved net Sales of Rs.26417.42 Lacs and recorded a EBIDTA of Rs.2668.00 Lacs compared to previous year''s net Sales of Rs.22974.39 Lacs and EBIDTA of Rs.2349.16 Lacs.

As reported in the last year, your company has successfully launched Anaflam TH4/TH8 (skeletal muscle relaxant), Alamin RG/RGX (L-Arginine Sachets) and ADILAN (Isoxsuprine Tab/Inj.) .

During the current financial year, your company plans to further strengthen its gastro range of products by launching Rebeprazole and its combination. Also, we have plans to venture to Antiasthmatic and Infertility market.

Your Directors are hopeful of further growth in sales and better financial performance during the current year.

DIVIDEND

The Board of Directors of your Company is pleased to recommend payment of dividend of Rs.4.50 per equity share of Rs.10/- each for the financial year ended 31st March, 2013 amounting to Rs.300.47 Lacs (inclusive of dividend distribution tax of Rs.43.65 Lacs).

FIXED DEPOSITS

The Company has outstanding public deposits amounting to Rs.843.50 Lacs as on 31st March 2013. There was no overdue deposit on 31st March, 2013 except Rs.21.80 Lacs (including accrued interest of Rs.1.80 Lacs) which remain unclaimed.

BOARD OF DIRECTORS

Pursuant to the provisions of Section 255 and 256 of the Companies Act, 1956 and in accordance with the provisions of Articles of Association of the Company, Shri Hemal Kampani and Shri P L Agarwal, Directors of the company, are liable to retire by rotation and being eligible, offer themselves for re-appointment.

The Board recommends their re-appointment.

As per Clause 49 of the Listing Agreement, a brief profile of the Directors seeking re-appointment is given in the Notice of AGM.

DIRECTORS'' RESPONSIBILITY STATEMENT

Pursuant to sub-section (2AA) of Section 217 of the Companies Act, 1956, the Board of Directors of the Company hereby state and confirm that :

i) in the preparation of the annual accounts, the applicable accounting standards have been followed alongwith proper explanation relating to material departures, if any ;

ii) the Directors had selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year ended on 31st March, 2013 and of the profit of the Company for the year ended as on date ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records for the year ended 31st March, 2013 in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities ; and

iv) the Directors had prepared the annual accounts on a ''going concern basis''.

PARTICULARS OF EMPLOYEES

Particular of Employees as required in term of provision of Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended are set out in Annexure-I to the Directors'' Report.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNING AND OUTGO

Particulars required under Section 217(1)(e) of the Companies Act, 1956 read with the Companies (Disclosure of Particulars in the Report of Board of Directors) Rules, 1988 regarding Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo, are given in Annexure-II forming part of this Report.

CORPORATE GOVERNANCE

Your Company believes Corporate Governance is at the core of stake holders'' satisfaction. The Annual Report contains a separate section on Corporate Governance which forms part of this Report.

The Compliance Report on Corporate Governance and a certificate from M/s. G. Basu & Co., Kolkata, Chartered Accountants, Statutory Auditors of the Company regarding compliance of the condition of corporate governance, as stipulated under clause 49 of the listing agreement with the stock exchange, is forming part of this Report.

As a measure of good corporate governance, M/s. Ashok Kumar Daga, a Practising Company Secretary conducts Annual Secretarial Compliance Audit of the company.

RESEARCH & DEVELOPMENT ACTIVITY :

Unlike other manufactory, there is fast product obsoletion in Pharma industry. Therefore, the product portfolio is a dynamic one and requires continuous strengthening with new developments. Ever changing regulatory requirements calls for back up of database with Quality Assurance. Companies are making more and more investments in R&D not only to support the changing regulatory requirements but also to remain afloat with continuous flow of products developed at R&D.

The Company''s Research & Development unit at Kolkata has been recognised by Department of Scientific and Industrial Research (DSIR), Government of India. The Research & Development section of the Company has been engaged in developing innovative process developments, analytical methods and process validations. It has also been working on development of new products.

CREDIT PROFILE :

CRISIL Limited has reaffirmed [CRISIL A-Stable] (pronounced as CRISIL A minus/Stable) in respect of Long Term rating. This rating indicates adequate degree of safety regarding timely servicing of financial obligations. Such instruments carry low credit risk.

CRISIL Limited has reaffirmed [CRISIL A1] (pronounced as CRISIL A One) in respect of Short Term rating. This rating indicates strong degree of safety regarding timely payment of financial obligations. Such instruments carry low credit risk.

LISTING OF SHARES

The equity shares of your Company are at present listed on BSE Ltd. Your Directors confirm that the Annual Listing Fee for 2013-2014 has been paid to the said Stock Exchange.

AUDITORS

Statutory Auditors & Report

M/s. G. Basu & Co., Kolkata, Chartered Accountants, Statutory Auditors of the company, will retire at the conclusion of the ensuing Annual General Meeting and being eligible, offer themselves for re-appointment as Statutory Auditors for the financial year 2013-2014. The company has received required Certificates from them under section 224(1B) and section 226(3e) of the Companies Act, 1956, for such re-appointment.

Based on the recommendation of the Audit Committee, the Board of Director of the company proposes the re-appointment of M/s. G. Basu & Co., Kolkata, Chartered Accountants as Statutory Auditors of the Company and to fix their remuneration.

The comments on statement of accounts referred to the report of the Auditors are self-explanatory.

Cost Auditors and Cost Audit Report

The Central Government has approved the appointment of M/s. S. Gupta & Co., Kolkata, Cost Accountant, Registration No.000020 as Cost Auditor for conducting cost audit relating to Bulk Drugs and Formulations for the financial year 2012-2013.

The Audit Committee has also received a Certificate from the Cost Auditor under section 224 (1B) and section 233B(5) of the Companies Act, 1956, certifying their independence and arm''s length relationship with the Company. Pursuant to Cost Audit (Report) Rules, 2001, the due date for filing the Cost Audit Report for the financial year 2012 was 28th February, 2013 and the same was filed on 17th December, 2012 on the MCA website vide SRN No.S17644204 in respect of Bulk Drugs and Formulations.

ACKNOWLEDGEMENTS

The Board gratefully acknowledges the support given by medical profession, trade, shareholders, company''s bankers and stockists. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

For and on behalf of the Board of Directors

Kolkata (A K Kothari)

Dated : 29th May, 2013 Chairman & Managing Director


Mar 31, 2012

The Directors have pleasure in presenting their report on the working of the Company alongwith the Audited Accounts for the year ended 31st March, 2012 FINANCIAL RESULTS

Year ended Year ended 31.03.2012 31.03.2011 (Rs.in Lacs) (Rs. in Lacs) (Rs.in Lacs) (Rs. in Lacs)

Gross Profit for the year 2101.42 2637.12

Less: Depreciation 977.57 996.41

Profit before tax 1123.85 1640.71

Less: Provision for Taxation

Current 385.00 649.50

Deferred (14.61) (93.37)

Provision for earlier year's written back (9.38) 361.01 0.00 556.13

Net Profit 762.84 1084.58

Add : Balance brought forward from from previous year 536.12 450.02

Less: Proposed Dividend 256.82 256.82

Corporate Dividend Tax 41.66 41.66

Transfer to General Reserve 500.00 798.48 700.00 998.48

Balance Carried Forward 500.48 536.12

WORKING RESULTS

During the year under review, your Company achieved net Sales of Rs 22974.39 Lacs and recorded a Gross Profit of Rs 2101.42 Lacs compared to previous year's net Sales ofRs 21849.48 Lacs and Gross Profit ofRs 2637.12 Lacs.

As reported last year, Govt. of India pursuant to directives of Hon'ble High Court of Delhi, had revoked the ban on Placentrex Injection for PID and Placenterex topical application for wound healing with effect from 30th May, 2011. However, prohibition on some products under the "Placentrex Group" were not restored.

This act of prohibiting and revocating the earlier order by the Govt. Authorities had created some cloud of disbelief amongst the medical practitioners. Your company is gradually recovering from the setback and making all efforts to restore the confidence of doctors and revive Placentrex business.

As reported in the last year, your company has successfully launched UDCA & Silymarin combination - Actimarin/Actimarin Forte, Febuxostat - FBX 40/80/120, Dapoxetin - Amjoy, a drug for premature ejaculation and has also expanded its Vision Care basket with the launch of Sioflox and Siomox-KT.

During the current financial year, your company plans to launch Skeletal muscle relaxant, L-Arginine Sachets, Isoxsuprine Tab/Inj., Betahistine & Domperidone combination, Hormonal preparations and antiasthmatic drugs.

Your Directors are hopeful of further growth in sales and better financial performance during the current year.

DIVIDEND

Your Directors have recommended payment of Dividend of Rs 4.50 per equity share of Rs 10/- each for the financial year ended 31st March, 2012 amounting to Rs 298.48 Lacs (inclusive of Corporate Dividend Tax of Rs 41.66 Lacs).

FIXED DEPOSIT

As on 31st March, 2012, an amount of Rs 610.25 Lacs was outstanding as Fixed Deposit received from the public out of which matured amount of Rs 21.80 Lacs (including accrued interest of Rs 1.80 Lacs) remains unclaimed on the said date.

DIRECTORS' RESPONSIBILITY STATEMENT

Pursuant to sub-section (2AA) of Section 217 of the Companies Act, 1956, the Board of Directors of the Company hereby state and confirm that:

i) in the preparation of the annual accounts, applicable accounting standards have been followed alongwith proper explanation relating to material departures, if any;

ii) the Directors had selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

iv) the Directors had prepared the annual accounts on a going concern basis.

DISCLOSURE UNDER SECTION 217(2A) OF THE COMPANIES ACT, 1956

The Companies (Particulars of Employees) Rules, 1975 as amended are not applicable.

INFORMATION UNDER SECTION 217(1)(e) OF THE COMPANIES ACT, 1956

Information pursuant to Section 217(1)(e) of the Companies Act, 1956 dealing with Conservation of Energy and Technology Absorption etc. are set out in Annexure-I forming part of this Report.

CORPORATE GOVERNANCE

Pursuant to Clause 49 of the Listing Agreement with the Stock Exchange, the Management Discussion and Analysis Report forms part of the annual Report as an addition to the Directors' Report. Report on Corporate Governance alongwith Auditor's Certificate thereon is also annexed to the Directors' Report.

DIRECTORS

The Board have re-appointed Shri K. P. Mundhra as Executive Director and Shri A. K. Kothari as Chairman & Managing Director of the company from 1st April, 2012 and 1st July, 2012 respectively for further periods till 31st March, 2014. Resolutions seeking shareholders' approval will be placed before the ensuing Annual General Meeting for consideration.

Shri D. D. Binani and Shri Raiiv Singhi retire from the Board by rotation and being eligible offer themselves for re-appointment.

The Board recommends their re-appointment.

As per Clause 49 of the Listing Agreement, a brief profile of the Directors seeking re-appointment is given in the Notice of AGM.

LISTING OF SHARES

The shares of your Company are at present listed with Bombay Stock Exchange Ltd. Your Directors confirm that the Annual Listing Fee for 2012-2013 has been paid to the said Stock Exchange.

The Delhi Stock Exchange Association Ltd. has approved company's application for delisting of company's shares from their stock exchange with effect from 15th November, 2011.

AUDITORS

Statutory Auditors

M/s. G. Basu & Company, Chartered Accountants retire as Auditors of the Company and being eligible offer themselves for re-appointment. The Certificate as required under sub-section 1B of Section 224 and sub-section 3(e) of Section 226 of the Companies Act, 1956 has been obtained.

Cost Auditors and Cost Audit Report

The Central Government has approved the appointment of M/s. S. Gupta & Co., as Cost Auditor for conducting cost audit relating to Bulk Drugs & Formulations for the financial year 2011-2012.

The Audit Committee has also received a Certificate from the Cost Auditor certifying their independence and arm's length relationship with the company. Pursuant to Cost Audit(Report) Rules, 2001, the due date for filing the Cost Audit Report for the financial year 2010 - 2011 was 27th September, 2011 and the same was filed on 21st September, 2011 on the MCA website vide SRN No.B-20936738 in respect of Bulk Drugs, SRN No.B-20936878 in respect of Kolkata Formulations and SRN No. B-20936969 in respect of Ghaziabad Formulations

ACKNOWLEDGEMENTS

The Board gratefully acknowledges the support given by medical profession, trade, shareholders, company's bankers and stockists. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

For and on behalf of the Board of Directors

Kolkata (A. K. KOTHARI)

Dated : 29th May, 2012 Chairman & Managing Director


Mar 31, 2011

The Directors have pleasure in presenting their report on the working of the Company alongwith the Audited Accounts for the year ended 31st March, 2011

FINANCIAL RESULTS :

Year ended Year ended 31-03-2011 31-03-2010

Rs. Rs. Rs. Rs. (in Lacs) (in Lacs) (in Lacs) (in Lacs)

Gross Profit for the year 2637.12 2476.43

Less : Depreciation 996.41 904.83

Profit before tax 1640.71 1571.60

Less : Provision for Taxation

Current 649.50 545.00

Deferred (93.37) 556.13 (0.80) 545.80

Net Profit 1084.58 1027.40

Add : Balance brought forward from previous year 450.02 422.09

Less : Proposed Dividend 256.82 256.82

Corporate Dividend Tax 41.66 42.65

Transfer to General Reserve 700.00 998.48 700.00 999.47

Balance Carried Forward 536.12 450.02

WORKING RESULTS :

During the year under review, your Company achieved net Sales of Rs. 21849.48 Lacs and recorded a Gross Profit of Rs.2637.12 Lacs compared to previous year’s net Sales of Rs.20295.79 Lacs and Gross Profit of Rs.2476.43 Lacs registering a growth of 7.66% and 6.49% respectively over the last year.

As reported in the last year, your company has successfully launched uterine tonic-Siocare and Laxative combination-Evict Fibre and has also expanded its Anti-inflammatory & Analgesic range with launch of Anaflam XP

During the current financial year, your company plans to launch L-Arginine Sachets, Ursodeoxycholic Acid & Silymarin combination, Calcium preparation and a number of other new products.

The financial results for the year would have been much better but for prohibition on manufacture and sale of Company’s flagship product ‘Placentrex’ imposed by the Govt. Authorities w.e.f. 10th February, 2011 resulting in loss of sales and profit during the period from 10th February, 2011 to 31st March, 2011. Your company has filed a writ petition against this prohibition with Hon’ble High Court of New Delhi and the final verdict is awaited.

Your Directors are hopeful of further growth in sales and better financial performance during the current year.

DIVIDEND :

Your Directors have recommended payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each for the financial year ended 31st March, 2011 amounting to Rs. 298.48 Lacs (inclusive of Corporate Dividend Tax of Rs. 41.66 Lacs).

FIXED DEPOSIT :

As on 31st March, 2011, an amount of Rs. 699.25 Lacs was outstanding as Fixed Deposit received from the public out of which matured amount of Rs. 21.80 Lacs (including accrued interest of Rs. 1.80 Lacs) remains unclaimed on the said date.

DIRECTORS’ RESPONSIBILITY STATEMENT :

Pursuant to sub-section (2AA) of Section 217 of the Companies Act, 1956, the Board of Directors of the Company hereby state and confirm that :

i) in the preparation of the annual accounts, applicable accounting standards have been followed alongwith proper explanation relating to material departures, if any ;

ii) the Directors had selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period ;

iii) the Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities ;

iv) the Directors had prepared the annual accounts on a going concern basis.

DISCLOSURE UNDER SECTION 217(2A) OF THE COMPANIES ACT, 1956 :

The Companies (Particulars of Employees) Rules 1975 as amended are not applicable.

INFORMATION UNDER SECTION 217(1)(e) OF THE COMPANIES ACT, 1956 :

Information pursuant to Section 217(1)(e) of the Companies Act, 1956 dealing with Conservation of Energy and Technology Absorption etc. are set out in Annexure-I forming part of this Report.

CORPORATE GOVERNANCE :

Pursuant to Clause 49 of the Listing Agreement with the Stock Exchanges, the Management Discussion and Analysis Report forms part of the annual Report as an addition to the Directors’ Report. Report on Corporate Governance alongwith Auditor’s Certificate thereon is also annexed to the Directors’ Report.

DIRECTORS :

The Board have re-appointed Shri A K Kothari as Chairman & Managing Director of the company for a further period of one year with effect from 1st July, 2011. Resolution seeking shareholders’ approval will be placed before the ensuing Annual General Meeting for consideration.

Shri P L Agarwal and Shri A V Iyengar retire from the Board by rotation and being eligible offer themselves for re-appointment.

The Board recommends their re-appointment.

As per Clause 49 of the Listing Agreement, a brief profile of the Directors seeking re-appointment is given in the Notice of AGM.

LISTING OF SHARES :

The shares of your Company are at present listed with Bombay Stock Exchange Ltd. and The Delhi Stock Exchange Association Limited and your Directors confirm that all due Annual Listing Fee has been paid to the said Stock Exchanges.

AUDITORS :

M/s. G. Basu & Company, Chartered Accountants retire as Auditors of the Company and being eligible offer themselves for re- appointment. The Certificate as required under sub-section 1B of Section 224 and sub-section 3(e) of Section 226 of the Companies Act, 1956 has been obtained.

The Central Government has approved the appointment of M/s. S. Gupta & Co., as Cost Auditor for conducting cost audit relating to Bulk Drugs & Formulations for the financial year 2010-2011.

ACKNOWLEDGEMENTS :

The Board gratefully acknowledges the support given by medical profession, trade, shareholders, company’s bankers and stockists. The Board further expresses its appreciation for the services rendered by the executives, officers, staffs and workers of the Company at all levels.

For and on behalf of the Board of Directors

A K KOTHARI Chairman & Managing Director

Kolkata Dated : 30th May, 2011

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+